<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Neuropsychopharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Int. J. Neuropsychopharmacol</journal-id>
<journal-id journal-id-type="publisher-id">ijnp</journal-id>
<journal-title-group>
<journal-title>International Journal of Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1461-1457</issn>
<issn pub-type="epub">1469-5111</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>US</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29036632</article-id>
<article-id pub-id-type="pmc">5795357</article-id>
<article-id pub-id-type="doi">10.1093/ijnp/pyx088</article-id>
<article-id pub-id-type="publisher-id">pyx088</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fineberg</surname>
<given-names>Naomi A</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="aff" rid="AF0003">3</xref>
<xref ref-type="corresp" rid="c1"></xref>
<!--<email>naomi.fineberg@btinternet.com</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Apergis-Schoute</surname>
<given-names>Annemieke M</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaghi</surname>
<given-names>Matilde M</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Banca</surname>
<given-names>Paula</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gillan</surname>
<given-names>Claire M</given-names>
</name>
<xref ref-type="aff" rid="AF0007">7</xref>
<xref ref-type="aff" rid="AF0008">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Voon</surname>
<given-names>Valerie</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>Samuel R</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
<xref ref-type="aff" rid="AF0006">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cinosi</surname>
<given-names>Eduardo</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reid</surname>
<given-names>Jemma</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shahper</surname>
<given-names>Sonia</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bullmore</surname>
<given-names>Edward T</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahakian</surname>
<given-names>Barbara J</given-names>
</name>
<xref ref-type="aff" rid="AF0003">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robbins</surname>
<given-names>Trevor W</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
</contrib-group>
<aff id="AF0001"><label>1</label>Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire, United Kingdom</aff>
<aff id="AF0002"><label>2</label>University of Hertfordshire, Department of Postgraduate Medicine, College Lane Hatfield, United Kingdom</aff>
<aff id="AF0003"><label>3</label>Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom</aff>
<aff id="AF0004"><label>4</label>Behavioral and Clinical Neurosciences Institute, University of Cambridge, Cambridge, United Kingdom</aff>
<aff id="AF0005"><label>5</label>Department of Psychology, University of Cambridge, Cambridge, United Kingdom</aff>
<aff id="AF0006"><label>6</label>Cambridge and Peterborough NHS Foundation Trust, Cambridge, United Kingdom</aff>
<aff id="AF0007"><label>7</label>School of Psychology, Trinity College Dublin, Dublin, Ireland</aff>
<aff id="AF0008"><label>8</label>Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland</aff>
<author-notes>
<corresp id="c1">Correspondence: Naomi A. Fineberg, MRCPsych, Hertfordshire Partnership University NHS Foundation Trust, Rosanne House, Parkway, Welwyn Garden City, Hertfordshire, AL8 6HG, UK (<email>naomi.fineberg@btinternet.com</email>).</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2017-09-23" pub-type="epub">
<day>23</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>9</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>21</volume>
<issue>1</issue>
<fpage>42</fpage>
<lpage>58</lpage>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press on behalf of CINP.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="pyx088.pdf"></self-uri>
<related-article ext-link-type="doi" id="d35e200" related-article-type="companion" xlink:href="10.1093/ijnp/pyx101"></related-article>
<abstract>
<title>Abstract</title>
<p>Compulsions are repetitive, stereotyped thoughts and behaviors designed to reduce harm. Growing evidence suggests that the neurocognitive mechanisms mediating behavioral inhibition (motor inhibition, cognitive inflexibility) reversal learning and habit formation (shift from goal-directed to habitual responding) contribute toward compulsive activity in a broad range of disorders. In obsessive compulsive disorder, distributed network perturbation appears focused around the prefrontal cortex, caudate, putamen, and associated neuro-circuitry. Obsessive compulsive disorder-related attentional set-shifting deficits correlated with reduced resting state functional connectivity between the dorsal caudate and the ventrolateral prefrontal cortex on neuroimaging. In contrast, experimental provocation of obsessive compulsive disorder symptoms reduced neural activation in brain regions implicated in goal-directed behavioral control (ventromedial prefrontal cortex, caudate) with concordant increased activation in regions implicated in habit learning (presupplementary motor area, putamen). The ventromedial prefrontal cortex plays a multifaceted role, integrating affective evaluative processes, flexible behavior, and fear learning. Findings from a neuroimaging study of Pavlovian fear reversal, in which obsessive compulsive disorder patients failed to flexibly update fear responses despite normal initial fear conditioning, suggest there is an absence of ventromedial prefrontal cortex safety signaling in obsessive compulsive disorder, which potentially undermines explicit contingency knowledge and may help to explain the link between cognitive inflexibility, fear, and anxiety processing in compulsive disorders such as obsessive compulsive disorder.</p>
</abstract>
<kwd-group>
<kwd>cognitive domains</kwd>
<kwd>neural circuitry</kwd>
<kwd>treatment</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Wellcome Trust</named-content>
<named-content content-type="funder-identifier">10.13039/100004440</named-content>
</funding-source>
<award-id>110049/Z/15/Z</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Compulsions are stereotyped behaviors, performed according to rigid rules and designed to reduce or avoid unpleasant consequences (<xref ref-type="bibr" rid="CIT0025">Chamberlain et al., 2009</xref>). The newly created DSM-5 Obsessive Compulsive and Related Disorders (OCRDs) (<xref ref-type="bibr" rid="CIT0004">APA 2013</xref>) are defined by the presence of compulsions. However, compulsive behaviors are observed in many other psychiatric disorders, particularly those involving deficient impulse control. For example, much of the behavior associated with disorders of eating, substance addiction, and “behavioral addiction,” such as pathological gambling or problematic internet usage (<xref ref-type="bibr" rid="CIT0077">Ioannidis et al., 2016</xref>), is theorized to shift over the course of time from reward-driven impulsive (rapid, reckless) to compulsive activity (<xref ref-type="bibr" rid="CIT0043">Everitt and Robbins, 2005</xref>; <xref ref-type="bibr" rid="CIT0124">Robbins et al., 2012</xref>). These disorders share a profound experience of “lack of control,” thought to derive from the dysfunctional inhibition of thoughts and behaviors naturally prone to excess, for example, grooming, eating, purging, gambling, and checking. As poorly understood lifespan disorders, they are difficult to treat and responsible for considerable psychiatric (depression, suicide) and somatic morbidity and cost to the individual and society as a whole (<xref ref-type="bibr" rid="CIT0074">Hollander et al., 2016</xref>).</p>
<p>Regrettably, the development of new treatments in psychiatry is slowing, related, at least in part, to difficulties translating positive results from experiments using nonhuman illness models to the clinical setting. These difficulties align with growing concern about the scientific utility of the existing diagnostic systems (ICD-10, <xref ref-type="bibr" rid="CIT0153">World Health Organisation 1992</xref>, DSM-5, <xref ref-type="bibr" rid="CIT0004">APA 2013</xref>) that tend to define psychiatric disorders according to symptoms and syndromes and give less prominence to neuropsychological substrates. It is thought likely that the considerable biological heterogeneity that exists within the current taxonomy is hampering identification of the underpinning mechanisms that may serve as new therapeutic targets. In response, the EU Roadmap for Mental Health Research in Europe (<xref ref-type="bibr" rid="CIT0069">Haro et al., 2014</xref>) and the US National Institute of Mental Health, Research Domain Criteria (<ext-link ext-link-type="uri" xlink:href="https://www.nimh.nih.gov/research-priorities/rdoc">https://www.nimh.nih.gov/research-priorities/rdoc</ext-link>; <xref ref-type="bibr" rid="CIT0076">Insel et al., 2010</xref>) have called for new ways of classifying psychopathology to better support treatment development based on dimensions of observable behavior with established biological validity, irrespective of diagnosis. Identifying the pathophysiological mechanisms underpinning compulsivity as a trans-diagnostic, neuropsychological domain would therefore be expected to advance the search for new treatment targets and support innovation in developing evidence-based treatments (<xref ref-type="bibr" rid="CIT0047">Fineberg et al 2013a</xref>).</p>
<p>Many different compulsive disorders are found clustered within the same individual (comorbidity) or within the families of affected individuals, implying that vulnerability to these disorders is mediated via shared pathophysiological mechanisms (<xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>). The investigation of endophenotypes (intermediate phenotypes) that lie closer than do the expressed behaviors (phenotypes) to the genetic and environmental origins of compulsive disorders (<xref ref-type="bibr" rid="CIT0061">Gottesman and Gould, 2003</xref>; <xref ref-type="bibr" rid="CIT0022">Chamberlain and Menzies, 2009</xref>), such as changes in cognitive performance, or structural and functional brain imaging abnormalities, is expected to provide a clearer understanding of the biological processes underpinning these disorders.</p>
<p>Based on emerging data from the neurosciences, this narrative review, which was first delivered as a plenary lecture at the 2016 Annual Congress of the International College of Neuropsychopharmacology (<xref ref-type="bibr" rid="CIT0052">Fineberg et al., 2016</xref>), appraises the results of a decade of research by the authors dedicated to exploring the neuropsychological underpinnings of the OCRDs, as examples of compulsive disorders, from the perspective of diagnosis, evidence-based treatments, candidate neuro-psychological endophenotypes, and associated neural circuitry. The research builds upon previous and ongoing research by other groups and, as it has progressed, has generated testable models of compulsivity as a biologically relevant trans-diagnostic domain that could be expected to advance diagnostic classification and identify new avenues for treatment, including novel psychological, pharmacological, and somatic treatment targets for these disabling and intransigent disorders.</p>
<sec id="s2">
<title>The Obsessive-Compulsive and Related Disorders</title>
<p>The DSM-5 OCRD cluster, comprising obsessive–compulsive disorder (OCD), body dysmorphic disorder (BDD), hoarding disorder, hair-pulling disorder, and skin-picking disorder, represents some of the most costly, functionally disabling, and treatment-resistant brain disorders. By gathering together diagnoses previously listed in the DSM-IV under Anxiety Disorders, Somatoform Disorders, and Impulse-Control Disorders Not Elsewhere Classified, this new classification aims to advance the scientific study of the disorders as well as to improve their clinical recognition and management. The disorders commonly occur together and yet are surprisingly poorly recognized, as individuals are often not forthcoming about their symptoms (e.g., due to a sense of shame, or lack of knowledge that these problems constitute recognized mental disorders). As a result, there is usually a considerable time-lag, in the case of OCD, amounting to approximately 15 years, before the correct diagnosis is made and the correct treatments initiated. The duration of untreated illness represents one of the principal factors determining clinical and health outcomes (<xref ref-type="bibr" rid="CIT0034">Dell’Osso et al., 2013</xref>), emphasizing the importance of early detection, especially for child and adolescent onset OCD (<xref ref-type="bibr" rid="CIT0047">Fineberg et al., 2013a</xref>). It is to be hoped that by introducing this new classification, clinicians would be more likely to enquire about and detect the other disorders. It is fully expected that the forthcoming ICD revision will adopt a similar approach and may even include additional new diagnoses among the OCRD grouping, such as olfactory reference syndrome (<xref ref-type="bibr" rid="CIT0086">Marras et al., 2016</xref>).</p>
<p>OCRDs are generally thought to be highly heritable (hoarding disorder, Iervolino et al., 2009; OCD, <xref ref-type="bibr" rid="CIT0103">Nestadt et al., 2010</xref>; BDD, <xref ref-type="bibr" rid="CIT0095">Monzani et al., 2012</xref>) lifespan disorders (reviewed in <xref ref-type="bibr" rid="CIT0138">Steketee, 2011</xref>; <xref ref-type="bibr" rid="CIT0004">APA 2013</xref>), though episodic forms of OCD, hair pulling, and skin picking are seen. They are characterized by the irresistible urge to perform distressing and time-consuming compulsive acts. Of these disorders, OCD has been subject to most study and is arguably the most well understood. OCD affects approximately 3% of the general population, though only a fraction of affected individuals present for treatment. Of considerable interest, subthreshold OCD is found to be extremely common and such cases share a similar age of onset and symptom trajectory as OCD, suggesting a natural continuum of compulsive behavior exists affecting as many as 20% of the general population (<xref ref-type="bibr" rid="CIT0164">Fineberg et al., 2013b</xref>).</p>
<p>Patients with OCD show difficulty in flexibly shifting attentional focus away from distressing intrusive, perseverative thoughts (obsessions) and behaviors (compulsions) (<xref ref-type="bibr" rid="CIT0046">Fineberg et al., 2010</xref>, <xref ref-type="bibr" rid="CIT0050">2014</xref>). Washing, checking, ordering, and arranging compulsions are extremely common. Whereas traditional learning-based psychological models of OCD posit harm avoidance as the major reinforcer of compulsive behaviors, some symptoms of OCD, especially those concerned with ordering and arranging to achieve symmetry, appear to reflect a need to make the environment “feel right.” Growing evidence suggests these symptoms represent a separate OCD subgroup, in which compulsions are driven by the urge to avoid an unpleasant “not just right feeling.” The “not just right feeling” has been found to be associated with an earlier age of OCD onset and the presence of sensory processing difficulties (<xref ref-type="bibr" rid="CIT0070">Hellriegel et al., 2016</xref>), implicating the involvement of neuro-developmental mechanisms akin to autism spectrum disorder (ASD) in its etiology.</p>
<p>Hoarding disorder is a separate, poorly understood, and highly treatment refractory OCRD that involves the compulsive acquisition of new items and difficulty discarding owned items. These hoarding behaviors can also be viewed as an expression of the need to make the environment “feel right.” Typical responses when asking individuals what they would think/feel if we threw out a “treasured item,” which may be an old sweet paper, bus ticket, etc. are “it feels like I am missing part of me, it does not feel right” (<xref ref-type="bibr" rid="CIT0054">Frost and Steketee, 2010</xref>). Hoarding compulsions are also commonly found in patients with OCD as well as those with neurodevelopmental disorders such as ASD. In young people with OCD, hoarding is associated with prominent executive function deficits (<xref ref-type="bibr" rid="CIT0106">Park et al., 2016</xref>). Hair-pulling disorder and skin-picking disorder, on the other hand, are defined by more obviously disinhibited behavior, in the form of repetitive, body-focused grooming habits that can be considered as either predominantly impulsive or compulsive, depending on the nature of the symptoms expressed (<xref ref-type="bibr" rid="CIT0090">Chamberlain et al., 2007</xref>).</p>
<p>Other phenotypic signs of an altered neurodevelopmental trajectory are also commonly observed in patients with OCRDs, such as traits or symptoms of tic disorder, ASD, and attention deficit hyperactivity disorder. These comorbid traits and diagnoses appear to cluster in the same patient or within their family members, hinting that shared, heritable neuro-behavioral mechanisms contribute to the expression of many compulsive disorders (<xref ref-type="bibr" rid="CIT0037">de Vries et al., 2016</xref>; <xref ref-type="bibr" rid="CIT0150">Wikramanayake et al., 2017</xref>). Cases of tic-related OCD tend to have a male predominance (similar to ASD), an earlier age of onset, and a higher proportion of OCD symptoms related to symmetry, “not just-right experiences,” and forbidden thoughts compared with non-tic-related OCD (<xref ref-type="bibr" rid="CIT0113">Prado et al., 2008</xref>). Additionally, tic-related OCD shows a more favorable response to adjunctive treatment with dopamine antagonist drugs (<xref ref-type="bibr" rid="CIT0014">Bloch et al., 2006</xref>). In response to the emerging evidence, the DSM-5 has highlighted the presence of tic as the first neuro-behavioral specifier of a clinically relevant OCD subtype. Studies in patients with Tourette’s syndrome indicate a complex genetic relationship exists between tic disorder, OCD, and attention deficit hyperactivity disorder. One such recent study (<xref ref-type="bibr" rid="CIT0031">Darrow et al., 2016</xref>) identified two independent, heritable, symptom-based factors (one involving the urge to attain symmetry, the other involving behavioral disinhibition) as possible trans-diagnostic phenotypes of compulsive behavior.</p>
</sec>
<sec id="s3">
<title>Evidence-Based Treatment of OCD and Related Disorders</title>
<p>
<xref ref-type="fig" rid="F1">Figure 1</xref> summarizes the evidence-based treatment of the OCRDs based on a systematic review (<xref ref-type="bibr" rid="CIT0064">Grant et al., 2014a</xref>). Apart from some studies of OCD and BDD, the pharmacotherapies were almost exclusively tested in small un-replicated trials, and the psychotherapies were not rigorously tested against a matched control of fair comparison. Randomized controlled treatment trials of adequate size and power to enable the detection of predictive outcome markers are urgently needed to drive forward the clinical management of these disorders on an individualized basis (<xref ref-type="bibr" rid="CIT0174">Sachdev et al., 2017</xref>).</p>
<p>OCD typically responds to pharmacological treatment with serotonin reuptake inhibitors (SRIs; clomipramine and selective SRIs, SSRIs) according to a dose-response relationship (higher doses needed for better clinical response) or to SSRIs combined with antipsychotic agents, and to cognitive behavior therapy (CBT) involving exposure and response prevention (ERP) (<xref ref-type="bibr" rid="CIT0051">Fineberg et al., 2015</xref>). Antipsychotics represent first-line treatment for Tourette’s syndrome and adjunctive antipsychotic may be preferentially effective in OCD with comorbid tics (<xref ref-type="bibr" rid="CIT0014">Bloch et al., 2006</xref>). BDD has been studied less intensively than OCD but also shows a similar treatment response (<xref ref-type="bibr" rid="CIT0145">Veale et al., 2014</xref>; <xref ref-type="bibr" rid="CIT0117">Rashid et al., 2015</xref>; <xref ref-type="bibr" rid="CIT0111">Phillips et al., 2016</xref>), though it remains less clear as to whether higher SSRI dosages and adjunctive antipsychotic are of value (reviewed in <xref ref-type="bibr" rid="CIT0177">Reghunandanan et al., 2015c</xref>). The compulsions associated with ASD also respond to SSRI, though the increased risk of SSRI-induced adverse effects in the autistic population, such as behavioral activation and agitation, warrant care in dosage titration and subject selection (<xref ref-type="bibr" rid="CIT0080">Kolevzon et al., 2006</xref>). Hoarding behavior has been mainly studied in the context of comorbid OCD and may respond to SSRI or venlafaxine (Saxena and Sumner, 2014), but as yet no effective pharmacological treatment has been established for primary hoarding disorder. CBT, even when delivered intensively over long periods, has so far been found to produce only limited improvement in hoarding behavior (<xref ref-type="bibr" rid="CIT0141">Uhm et al., 2016</xref>). In hair-pulling disorder the data supporting the efficacy of SSRI and clomipramine are also not strong. Unlike OCD, but similar to impulse control disorders, SSRIs appeared to have a rapid onset of effect which was not sustained over time (<xref ref-type="bibr" rid="CIT0129">Rothbart et al., 2013</xref>). Habit reversal therapy, rather than ERP, has emerged as the psychological therapy of choice (<xref ref-type="bibr" rid="CIT0089">McGuire et al., 2014</xref>). Other data from single randomized controlled trials in hair-pulling disorder suggest that olanzapine (an antipsychotic agent) (<xref ref-type="bibr" rid="CIT0143">Van Ameringen et al., 2010</xref>) and n-acetyl cysteine (an amino acid compound) (<xref ref-type="bibr" rid="CIT0062">Grant et al., 2009</xref>) could be effective. Naltrexone, an opiate antagonist, produced substantial benefits in a small open-label study of children with hair pulling disorder (<xref ref-type="bibr" rid="CIT0036">De Sousa, 2008</xref>), but the drug was not effective in a double-blind placebo-controlled study. However, those in this study with a family history of addiction showed a greater (but not statistically significant) decrease in the urge to hair-pull (<xref ref-type="bibr" rid="CIT0065">Grant et al., 2014b</xref>). Skin picking disorder has been barely studied to date, but as with hair-pulling disorder, shows some response to SSRI and n-acetyl cysteine (reviewed in <xref ref-type="bibr" rid="CIT0177">Reghunandanan et al., 2015c</xref>).</p>
<p>Approximately 40% of OCD patients fail to respond to standard forms of therapy (<xref ref-type="bibr" rid="CIT0051">Fineberg et al., 2015</xref>). Of great interest, a wide range of pharmacological compounds have been tested in treatment-resistant OCD and some have been found to be effective in small-sized trials, implicating a multiplicity of potential treatment targets and mechanisms (see <xref ref-type="fig" rid="F2">Figure 2</xref>)</p>
<fig fig-type="figure" id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Evidence-based treatments for OCRDS. Adapted from Grant J, Chamberlain S, Odlaug B, Clinical Guide to OCRDs, Oxford, 2014a. Treatments with robust evidence of efficacy derived from randomized controlled trials of fair comparison are highlighted in bold black type. ACT,acceptance and commitment therapy; BDD, body dysmorphic disorder; BT,behavior therapy; CBT,cognitive behavior therapy; ERP,exposure and response prevention; OCD, obsessive compulsive disorder; rTMS,repetitive transcranial magnetic stimulation; Rx, Medication; SSRI,selective serotonin reuptake inhibitor.</p>
</caption>
<graphic xlink:href="pyx08801"></graphic>
</fig>
<fig fig-type="figure" id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>SSRI-Resistant OCD: Small sized randomized controlled trials showing efficacy vs. placebo.</p>
</caption>
<graphic xlink:href="pyx08802"></graphic>
</fig>
<p>Thus, notwithstanding the limitations of the study data, some compulsive disorders (e.g., OCD, BDD) exhibit a strikingly similar treatment response to SRIs, suggesting that the underpinning neural mechanisms may overlap significantly, and possibly also with those relating to anxiety and affective disorders. In contrast, hair pulling and skin picking disorders, which are also characterized by prominent impulse control and addictive symptomatology, respond better to treatment with drugs acting on dopamine, glutamate, opioid, and noradrenergic systems, that is, potentially more like impulse-control disorders or even behavioral addictions (e.g. <xref ref-type="bibr" rid="CIT0065">Grant et al., 2014b</xref>), whereas those with SRI-resistant OCD respond to similar agents in combination with SSRI, and OCD with prominent motor symptoms (tics, habits) may respond preferentially to adjunctive dopamine antagonists, known to modulate the cortico-striatal motor circuitry involved in Tourette’s syndrome and animal models of excessive habit behavior (<xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>; <xref ref-type="bibr" rid="CIT0055">Furlong et al., 2014</xref>).</p>
<p>The pharmacological treatment response may be of particular value for parsing psychiatric disorders and defining the boundaries of diagnostic groups, as it depends on underpinning biological mechanisms. As the treatment trial data for the OCRDs accrues, it is possible that for some disorders more convincing similarities will be found with disorders classified elsewhere in the DSM, such as the behavioral addictions (e.g., pathological gambling), impulse control disorders (e.g., intermittent explosive disorder), or even neurodevelopmental disorders (e.g. ASD), challenging their classification within the OCRDs grouping. Alternatively, by taking a dimensional (impulsive-compulsive-habit) approach to the psychopharmacology of the OCRDs, the emerging evidence may instead be interpreted to support the inclusion of some of these other disorders into an expanded OCRDs grouping (<xref ref-type="bibr" rid="CIT0174">Sachdev et al., 2017</xref>).</p>
</sec>
<sec id="s4">
<title>Neuropsychological Endophenotypes</title>
<p>Psychiatric symptoms and cognitive deficits can be conceptualized as disordered structure, connectivity, and function in large-scale neural networks. A series of evolutionarily well-conserved, parallel, cortico-striato-thalamo-cortical (CSTC) circuits are believed to underpin the expression of compulsive behaviors (<xref ref-type="bibr" rid="CIT0003">Alexander et al., 1986</xref>; <xref ref-type="bibr" rid="CIT0029">Cummings et al., 1993</xref>; <xref ref-type="bibr" rid="CIT0067">Groenewegen and Uylings 2000</xref>). These circuits include direct (positive feedback) and indirect (negative feedback) pathways, projecting from specific cortical areas to the corresponding subregions of the striatum and thalamus with recurrent projections to the cortex. They are involved in diverse computational activities, including reward processing, action selection, habit formation, and motor control (<xref ref-type="bibr" rid="CIT0006">Arnsten et al., 2011</xref>; <xref ref-type="bibr" rid="CIT0124">Robbins et al., 2012</xref>). They play an important role in recognizing behaviorally significant stimuli (and in error detection) and in regulating goal-directed responses (<xref ref-type="bibr" rid="CIT0085">Lovinger, 2010</xref>) and may therefore be particularly important for OCRDs. The anatomical overlap and functional interplay between these circuits may explain why compulsive behavior occurs in so many psychiatric syndromes.</p>
</sec>
<sec id="s5">
<title>Historical Perspectives</title>
<p>Early indications that the compulsive behaviors seen in OCD and other compulsive disorders may be mediated by CSTC circuits (reviewed in <xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>) included research showing an association between postencephalitis Parkinsonian, obsessive-compulsive symptoms and striatal lesions (Cheyette and Cummings, 1995). OCD symptoms were also found to occur in a range of other neurological disorders involving striatal pathology, including Tourette’s syndrome, Sydenham’s chorea, Huntington’s disorder, and Parkinson’s disorder (<xref ref-type="bibr" rid="CIT0112">Pitman et al., 1987</xref>; <xref ref-type="bibr" rid="CIT0116">Rapoport, 1989</xref>; <xref ref-type="bibr" rid="CIT0137">Stein et al., 1994</xref>). OCD patients have subsequently been found to demonstrate abnormalities in a broad series of measures used in neuropsychiatric (e.g., neurological soft signs, olfactory identification, evoked potentials, intra-cortical inhibition) and neuropsychological (e.g., executive function) research (<xref ref-type="bibr" rid="CIT0137">Stein et al., 1994</xref>; <xref ref-type="bibr" rid="CIT0114">Purcell et al., 1998a</xref>). These abnormalities have consistently implicated CSTC dysfunction and impaired control of the inhibition of thoughts and behaviors (reviewed in <xref ref-type="bibr" rid="CIT0096">Morein-Zamir et al., 2010</xref>). Some evidence has suggested that they are relatively specific to disorders characterized by compulsive behaviors (<xref ref-type="bibr" rid="CIT0115">Purcell et al., 1998b</xref>; <xref ref-type="bibr" rid="CIT0110">Phillips et al., 2010</xref>).</p>
<p>Advances in brain imaging have provided persuasive neuroanatomical data for OCD (<xref ref-type="bibr" rid="CIT0118">Rauch and Baxter, 1998</xref>; <xref ref-type="bibr" rid="CIT0066">Graybiel and Rauch, 2000</xref>; <xref ref-type="bibr" rid="CIT0148">Whiteside et al., 2004</xref>; <xref ref-type="bibr" rid="CIT0087">Mataix-Cols and van den Heuvel, 2006</xref>; <xref ref-type="bibr" rid="CIT0090">Menzies et al., 2007</xref>; <xref ref-type="bibr" rid="CIT0094">Milad and Rauch, 2012</xref>) as well as Tourette’s syndrome (<xref ref-type="bibr" rid="CIT0068">Groenewegen et al., 2003</xref>), trichotillomania (<xref ref-type="bibr" rid="CIT0025">Chamberlain et al., 2009</xref>), impulse control disorders in Parkinson’s disease (<xref ref-type="bibr" rid="CIT0144">van den Heuvel et al., 2010</xref>), and addictive disorders (<xref ref-type="bibr" rid="CIT0043">Everitt and Robbins, 2005</xref>). Functional imaging in OCD has demonstrated increased activity in CSTC circuits connecting the orbitofrontal cortex, cingulate cortex, and striatum, both at rest and especially during exposure to feared stimuli (reviewed in <xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>). Somewhat different circuits may be involved in mediating different OCD symptom clusters such as hoarding (<xref ref-type="bibr" rid="CIT0131">Saxena et al., 2004</xref>; Mataix-Cols et al., 2005). The use of sophisticated cognitive and affective paradigms has generated new heuristics regarding the role of these circuits (Fitzgerald et al., 2004; <xref ref-type="bibr" rid="CIT0123">Remijnse et al., 2006</xref>); for example, during implicit learning, OCD subjects failed to show an expected increase in striatal activity and instead activated temporal cortex regions (<xref ref-type="bibr" rid="CIT0120">Rauch et al., 2001</xref>). The observation that some behavioral challenges, such as exposure to OCD cues, induce over-activation of the orbitofrontal cortex on functional imaging and others induce underactivation (e.g. <xref ref-type="bibr" rid="CIT0023">Chamberlain et al., 2008</xref>) may be explained by functional segregation within the orbitofrontal cortex.</p>
<p>Pediatric imaging research has also supported the involvement of CTSC circuits in OCD (reviewed in <xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>) and potentially offers the promise of being able to determine the evolution of brain abnormalities over time (<xref ref-type="bibr" rid="CIT0126">Rosenberg and Keshavan, 1998</xref>, Rosenberg et al., 2011). Abnormal structure or function in other brain regions such as the temporal lobe structures involved in memory and fear processing (<xref ref-type="bibr" rid="CIT0075">Hugo et al., 1999</xref>; <xref ref-type="bibr" rid="CIT0155">Zungu-Dirwayi, 1999</xref>, <xref ref-type="bibr" rid="CIT0139">Szeszko et al., 1999</xref>) and the supra marginal gyrus and the parietal lobe involved in the initiation and flexible control of instrumental behavior (<xref ref-type="bibr" rid="CIT0023">Chamberlain et al., 2008</xref>; <xref ref-type="bibr" rid="CIT0092">Meunier et al., 2012</xref>) have less commonly been found in OCD. However, recent meta- and mega-analyses of structural imaging data collected from research sites worldwide found distinct patterns of subcortical abnormalities in pediatric and adult OCD patients. The hippocampus as well as the pallidum seemed to be of importance in adult OCD, whereas the thalamus was involved in pediatric OCD (<xref ref-type="bibr" rid="CIT0015">Boedhoe et al., 2017</xref>).</p>
<p>Both successful SRI pharmacotherapy and behavioral therapy have been shown in OCD to normalize activity in CSTC circuits (<xref ref-type="bibr" rid="CIT0013">Baxter et al., 1992</xref>). Baseline structure or activity may differentially predict response to pharmacotherapy and psychotherapy (<xref ref-type="bibr" rid="CIT0017">Brody et al., 1998</xref>; <xref ref-type="bibr" rid="CIT0072">Hoexter et al., 2013</xref>) suggesting that different treatment modalities exert their clinical effects via different neuro-mechanisms (<xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>). Neurosurgical interruption of CSTC circuits may also reduce OCD symptoms as well as decrease striatal volume (<xref ref-type="bibr" rid="CIT0119">Rauch, 2000</xref>). Magnetic resonance spectroscopy has demonstrated alterations in glutamate metabolites in CSTC circuits (Rosenberg et al., 2004; Whiteside et al., 2006; <xref ref-type="bibr" rid="CIT0154">Yucel et al., 2007</xref>), in some cases normalizing after successful treatment with an SSRI (<xref ref-type="bibr" rid="CIT0127">Rosenberg et al., 2000</xref>). Evidence from the relatively few positron emission tomography (PET) ligand studies so far performed in OCD have identified abnormal binding of the serotonin transporter in cortical and subcortical areas (<xref ref-type="bibr" rid="CIT0122">Reimold et al., 2007</xref>; <xref ref-type="bibr" rid="CIT0088">Matsumoto et al., 2010</xref>; <xref ref-type="bibr" rid="CIT0071">Hesse et al., 2011</xref>) and of the striatal postsynaptic dopamine D2 receptor (<xref ref-type="bibr" rid="CIT0099">Moresco et al., 2007</xref>; <xref ref-type="bibr" rid="CIT0109">Perani et al., 2008</xref>; <xref ref-type="bibr" rid="CIT0035">Denys et al., 2013</xref>), which normalized after treatment with SSRI (<xref ref-type="bibr" rid="CIT0099">Moresco et al., 2007</xref>).</p>
<p>Techniques combining gene variants and brain imaging have been used to enhance the imaging findings. Several gene variants have been found to be associated with structural and functional alteration in CSTC circuits relevant to OCRDs (reviewed in <xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>). For example, in patients with OCD, genetic variation in the serotonin transporter was demonstrated to be associated with reduced orbitofrontal cortex volume as measured by magnetic resonance imaging (MRI) (<xref ref-type="bibr" rid="CIT0008">Atmaca et al., 2011</xref>; <xref ref-type="bibr" rid="CIT0071">Hesse, 2011</xref>) and the availability of the serotonin transporter in the putamen, nucleus accumbens, and hypothalamus as measured by PET (<xref ref-type="bibr" rid="CIT0071">Hesse et al., 2011</xref>).</p>
<p>Thus, in OCRDs, distributed network perturbation appears focused around the prefrontal cortex, caudate, putamen, and associated neurocircuitry. In OCD, convergent evidence points to deficient top-down inhibitory control in the prefrontal cortex nodes within this circuitry, coupled with the hijacking of flexible, contingency-dependent instrumental behavior in favor of excess habit generation mediated by dysfunction within the dorsal striatum (reviewed in <xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>; <xref ref-type="bibr" rid="CIT0059">Gillan et al., 2016a</xref>). Abnormal activation in the dorsal striatum, especially the head of the caudate nucleus and the putamen, is well replicated in the OCD literature (reviewed in <xref ref-type="bibr" rid="CIT0176">Reghunandanan et al., 2015a</xref>, <xref ref-type="bibr" rid="CIT0121">2015b</xref>), implicating the cognitive fronto-striatal loop communicating with the dorsolateral prefrontal cortex driving action selection and the motor loops driving goal-directed and habitual responses (<xref ref-type="bibr" rid="CIT0057">Gillan et al., 2014</xref>). This neuroanatomical model goes some way to explain the link between compulsive acts and harm-related thoughts and activities. Involvement of the putamen may be particularly relevant for the development of sensorimotor symptom such as tics. However, imaging research suggests that a wider range of CTSC circuits are involved in OCD, including systems responsible for reward processing more usually associated with addiction (<xref ref-type="bibr" rid="CIT0079">Klanker et al., 2013</xref>).</p>
<p>Surgical disconnection of this circuitry via stereotactic capsulotomy, cingulotomy, or limbic leucotomy has been used to treat severe, intractable OCD for several decades, with some evidence of success. A double-blind, sham-controlled trial has recently produced limited evidence of the efficacy and tolerability of ventral capsulotomy using gamma radio-surgery (<xref ref-type="bibr" rid="CIT0083">Lopes et al., 2014</xref>, <xref ref-type="bibr" rid="CIT0012">2015</xref>; <xref ref-type="bibr" rid="CIT0012">Batistuzzo et al., 2015</xref>). Promising results from a small number of treatment studies using invasive (deep brain stimulation) or noninvasive (transcranial magnetic stimulation, transcranial direct current stimulation) methods of neuro-modulation to target either cortical (orbito-frontal cortex, presupplementary motor area [pre-SMA]) or subcortical (nucleus accumbens, subthalamic nucleus) nodes or white matter tracts within this frontal-striatal circuitry (reviewed in <xref ref-type="bibr" rid="CIT0135">Senço et al., 2015</xref>) indicate new treatment possibilities for refractory obsessive-compulsive disorders. There is experimental evidence that in patients with OCD, deep brain stimulation targeted to the nucleus accumbens reduced excessive fronto-striatal connectivity within that circuit (<xref ref-type="bibr" rid="CIT0016">Bourne et al., 2012</xref>). The degree of such normalization correlated with reduced severity of symptoms (<xref ref-type="bibr" rid="CIT0044">Figee et al., 2013</xref>).</p>
</sec>
<sec id="s6">
<title>Neurocognitive Models of OCRDS</title>
<p>Neurocognitive changes are likely to be of great value for studying the neurobiology of psychiatric disorders, as they are theoretically more directly linked to brain structure and function than are the more complex higher-level phenotypes such as compulsive symptoms (<xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>). They are also more tractable to exploration across animal species (<xref ref-type="bibr" rid="CIT0030">Dalley et al., 2011</xref>) and are invaluable for clinicians and patients, providing a richer understanding of the phenotype. Of the available instruments, computerized cognitive tests have several advantages over pen and paper assessment. To date, a number of tasks derived from the Cambridge Neuropsychological Test Automated Battery (CANTAB), which includes tests that are adaptable for translational work in animals and for application during brain imaging, have shown considerable utility in fractionating cognitive processes in OCRDS and in localizing neural and neurochemical substrates.</p>
<p>Growing evidence from human and animal research using tests such as the CANTAB suggests that the neurocognitive mechanisms mediating behavioral inhibition (motor inhibition, cognitive inflexibility) and habit formation (shift from goal-directed to habitual responding) variably contribute toward vulnerability to compulsive activity in a broad range of compulsive disorders (reviewed in <xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>). Moreover, some of these deficits can be found in unaffected healthy relatives of OCD probands, suggesting they represent vulnerability or trait markers of compulsivity that also exist in nonpatient groups.</p>
<sec id="s7">
<title>Motor Inhibition</title>
<p>Multiple tiers of evidence, ranging from functional magnetic resonance imaging (fMRI) of individuals with focal frontal lobe lesions to animal research, have demonstrated that the inhibitory control of motor acts is sub-served by a neural network linking the right inferior frontal gyrus with its subcortical (including subthalamic) connections (<xref ref-type="bibr" rid="CIT0130">Rubia et al., 2003</xref>). Motor inhibition can be reliably tested using the stop-signal reaction time (SSRT) task (<xref ref-type="bibr" rid="CIT0007">Aron et al., 2005</xref>). Pharmacological manipulation in rodents and humans suggests that motor response inhibition, as indexed by the SSRT, falls under the neuro-modulatory influence of the norepinephrine system (<xref ref-type="bibr" rid="CIT0024">Chamberlain et al., 2006b</xref>, <xref ref-type="bibr" rid="CIT0019">2007a</xref>, <xref ref-type="bibr" rid="CIT0026">2013</xref>). In contrast, serotonin appears not to be centrally involved in this particular measure of impulsivity (<xref ref-type="bibr" rid="CIT0027">Clark et al., 2005a</xref>; <xref ref-type="bibr" rid="CIT0024">Chamberlain et al., 2006b</xref>; reviewed in <xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>). Paradoxically, compared with the SSRIs, there is only weak evidence to suggest that drugs acting to increase norepinephrine in the synaptic cleft, such as the SNRIs venlafaxine and duloxetine (<xref ref-type="bibr" rid="CIT0073">Hollander et al., 2003</xref>; <xref ref-type="bibr" rid="CIT0033">Dell’Osso et al., 2008</xref>; <xref ref-type="bibr" rid="CIT0040">Dougherty et al., 2015</xref>; <xref ref-type="bibr" rid="CIT0101">Mowla et al., 2016</xref>), are beneficial in OCD.</p>
<p>In a series of experiments using the SSRT (<xref ref-type="bibr" rid="CIT0020">Chamberlain et al., 2006a</xref>; Odlaug et al., 2011), evidence of significant impairment in motor inhibition, compared with healthy controls, was found in separate groups of patients with OCD, hair-pulling, and gambling disorder. However, this deficit was not seen in a study of community respondents with obsessive compulsive personality traits but without OCD (<xref ref-type="bibr" rid="CIT0045">Fineberg et al., 2015</xref>), suggesting that this form of inhibitory failure represents a concomitant of compulsive motor acts. In the case of OCD, SSRT performance was also highly significantly impaired in unaffected first-degree relatives (<xref ref-type="bibr" rid="CIT0021">Chamberlain et al., 2007b</xref>). In a MRI study of OCD families that included unaffected first-degree relatives (<xref ref-type="bibr" rid="CIT0090">Menzies et al., 2007</xref>), reduced cortical grey matter volume, coupled with increased basal ganglia grey matter volume, was found to correlate with SSRT indices of increased motor disinhibition. This study produced some of the earliest evidence of a structural imbalance in inhibitory cortico-striatal circuitry as a neurocognitive endophenotype of motor impulsivity in OCD. A more recent fMRI study demonstrated trait-dependent compensatory hyperactivity in the pre-SMA during the performance of the SSRT in both medication-free patients with OCD and unaffected siblings vs healthy controls, representing another neurocognitive endophenotype of motor impulsivity, in this case possibly related to inefficient neural processing within the pre-SMA in those vulnerable to OCD (<xref ref-type="bibr" rid="CIT0039">de Wit et al., 2012</xref>).</p>
</sec>
<sec id="s8">
<title>Cognitive Inflexibility</title>
<p>The intradimensional-extradimensional (ID-ED) shift task examines different components of attentional flexibility, including reversal learning, set formation, and inhibition, as well as shifting attention between stimulus dimensions (ED shift). Studies have demonstrated that ED shift is impaired in OCD and additionally in the unaffected first-degree relatives of OCD subjects (<xref ref-type="bibr" rid="CIT0020">Chamberlain et al., 2006a</xref>, <xref ref-type="bibr" rid="CIT0021">2007b</xref>; <xref ref-type="bibr" rid="CIT0142">Vaghi et al., 2016</xref>), suggesting that this aspect of cognitive inflexibility represents an endophenotype for OCD-related compulsivity. Moreover, ED shift impairment has been identified in patients with other obsessive-compulsive spectrum disorders, including obsessive-compulsive personality disorder (<xref ref-type="bibr" rid="CIT0045">Fineberg et al., 2015</xref>), schizophrenia with OCD (<xref ref-type="bibr" rid="CIT0108">Patel et al., 2010</xref>), and BDD (<xref ref-type="bibr" rid="CIT0078">Jefferies-Sewell et al., 2016</xref>). In a study of OCD hoarders compared with compulsive hoarders without OCD, significant EDS changes versus healthy controls were found in the OCD hoarders only, suggesting that the comorbid group was associated with greater cognitive inflexibility (<xref ref-type="bibr" rid="CIT0098">Morein-Zamir et al., 2014</xref>). Interestingly, another study found that hair-pulling disorder was not associated with EDS impairment, though OCD was, suggesting that cognitive inflexibility is not an essential component of repetitive acts of grooming (<xref ref-type="bibr" rid="CIT0020">Chamberlain et al., 2006a</xref>).</p>
<p>According to a recent fMRI analysis, compared with healthy controls, patients with OCD when tested in a resting state, irrespective of treatment status, showed reduced functional connectivity in circuits linking the dorsal caudate nucleus and its anatomical cortical projections (Vaghi et al., 2017). In addition, reduced connectivity between the left dorsal caudate and the ventrolateral prefrontal cortex, an area of cortex known to be associated with EDS in healthy controls (<xref ref-type="bibr" rid="CIT0125">Rogers et al., 2000</xref>), was associated with reduced OCD-related EDS performance. The reduced functional connectivity within this circuitry may account for the deficits in shifting attentional focus away from inappropriate intrusive thoughts and rituals, resulting in the perseverative behavior seen in OCD and acting as a potential biomarker of OCD.</p>
<p>Perseverating on a behavior that was once rewarded, but is later associated with harmful consequences, may reflect a lack of <italic>contingency-related</italic> cognitive flexibility. Exerting flexibility in learning and unlearning behavior based on (probabilistic) contingencies (probabilistic reversal-learning) may be particularly relevant for the development of compulsive tendencies (<xref ref-type="bibr" rid="CIT0050">Fineberg et al., 2014</xref>). Contingency-related flexibility is dependent on serotonin systems (<xref ref-type="bibr" rid="CIT0028">Clarke et al., 2005b</xref>) and has been linked to orbito-frontal cortex (OFC) function (<xref ref-type="bibr" rid="CIT0130">Rubia et al., 2003</xref>). Reduced activation of the OFC, lateral PFC, and parietal cortex was observed using task-related fMRI during reversal learning, not only in patients with OCD but also in their unaffected, never-treated relatives (Rejminse et al., 2006; <xref ref-type="bibr" rid="CIT0023">Chamberlain et al., 2008</xref>). Reversal-learning–related hypofunction, therefore, appears to be another candidate endophenotype for compulsivity that exists in people at increased genetic risk of OCD.</p>
<p>The identification of cognitive endophenotypes, such as those reflecting failures in motor inhibition and cognitive flexibility, opens new perspectives for the development of biomarkers that may be objectively quantified and used to parse compulsive disorders into more biologically homogeneous groups and that may even enable the development of personalized forms of treatment tailored to the individual (<xref ref-type="fig" rid="F3">Figure 3</xref>). For example, a small-sized, randomized, placebo-controlled trial in patients with skin picking disorder found that whereas lamotrigine was not efficacious in the group as a whole, benefit was seen in a subset of patients who exhibited relatively impaired cognitive flexibility on the EDS (<xref ref-type="bibr" rid="CIT0063">Grant et al., 2010</xref>). Results such as these highlight the need for randomized controlled studies of adequate power to prospectively examine the role of cognitive endophenotypes as predictors of treatment response across the full spectrum of compulsive disorders.</p>
<fig fig-type="figure" id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>Motor Inhibition, Cognitive Inflexibility and OC Spectrum Disorders. BDD, body-dysmorphic disorder; HPD, hair-pulling disorder; OCD, obsessive-compulsive disorder; OCPD, obsessive compulsive personality disorder; schizo-OCD, schizophrenia with OCD; SPD, skin-picking disorder.</p>
</caption>
<graphic xlink:href="pyx08803"></graphic>
</fig>
<fig fig-type="figure" id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p>Subdividing compulsive disorders according to neurocognitive domains: task performance, neural and neurochemical correlates.</p>
<p>Abbreviations: CANTAB, Cambridge Neuropsychological Test Automated Battery; OCPD, obsessive compulsive personality disorder; PFC, prefrontal cortex; SMA, supplementary motor area; VMPFC, ventromedial prefrontal cortex; ?, findings not assured.</p>
</caption>
<graphic xlink:href="pyx08804"></graphic>
</fig>
</sec>
<sec id="s9">
<title>Habit Learning</title>
<p>Compulsions are characterized by the persistence of activities that become disconnected from the prevailing environmental contingencies and lack an obvious relationship to the overall goal of the activity. In OCD, many patients are fully aware that their compulsive behaviors bear little to no relation to desirable outcomes, yet despite this knowledge, they continue to perform them. They often describe their compulsions as unwanted habits.</p>
<p>According to associative learning theories of instrumental behavior (<xref ref-type="bibr" rid="CIT0009">Balleine and Dickinson, 1998</xref>; <xref ref-type="bibr" rid="CIT0038">de Wit et al., 2009</xref>), actions are supported by at least 2 separate neural systems: a goal-directed system and a habitual system. When controlled by the goal-directed system, actions are purposeful inasmuch as they are flexibly performed to obtain desired goals or avoid undesired events. In contrast, habitual behaviors are considered lower order behaviors as they are performed as a routine response to specific environmental triggers and are insensitive to changes in environmental contingency (i.e., whether the action is contextually appropriate) or the outcome value of the behavior (i.e., whether the goal is actually desirable). After multiple repetitions, the habit system begins to render purposeful behavior rigid and automatic (<xref ref-type="bibr" rid="CIT0002">Adams et al., 1981</xref>, <xref ref-type="bibr" rid="CIT0001">1982</xref>), allowing simple acts to be conducted without effort. Exaggerated habit formation is consistent with the ego-dystonic stimulus-driven aspects of compulsivity. Compulsivity may thus arise at least in part from a shift from goal-directed action to habit, rendering behavior insensitive to its outcome or to the prevailing environmental contingencies.</p>
<p>The caudate nucleus is both pivotally involved in OCD, as well as in the dynamic regulation of goal-directed contingency learning, under the prevailing influence of the ventromedial prefrontal cortex (vmPFC), which tracks the current value of outcomes. In contrast, habitual acts involve the posterior lateral putamen, where stimulus-response associations are stored (<xref ref-type="bibr" rid="CIT0010">Balleine and O’doherty, 2010</xref>; <xref ref-type="bibr" rid="CIT0056">Gillan et al., 2011</xref>). In a recent fMRI study of OCD patients (<xref ref-type="bibr" rid="CIT0011">Banca et al., 2015</xref>), the experimental provocation of autobiographical compulsions in OCD patients was shown to reduce neural activation in brain regions implicated in goal-directed behavioral control (vmPFC, caudate nucleus) with concordant increased activation in regions implicated in habit learning (pre-SMA, putamen). This finding contrasts with previous evidence of generalized fronto-striato-limbic hyperactivation during OCD symptom evocation and provocation. This is likely due to differences in task nature and design. The cited study used a highly ecological symptom provocation paradigm, which overcame some of the limitations of previous studies, as well as, for the first time, subject-driven feedback that enabled the authors to specifically address the link between symptom provocation and compulsive urges to track the motor component of OCD. By contrast, the hyperactivation of caudate and medial prefrontal cortex found in previous studies could represent OCD-related changes in other cognitive domains such as imagery or autobiographical memory recollection, which are also processed in the medial prefrontal cortex (<xref ref-type="bibr" rid="CIT0082">Lin WJ et al., 2015</xref>).</p>
<p>Stronger support for a shift toward habitual responding is derived from the following series of studies that investigated the extent to which patients with OCD showed a bias towards performing stimulus-response habits and away from goal-directed activities. In the first of these studies (<xref ref-type="bibr" rid="CIT0056">Gillan et al., 2011</xref>), subjects were trained to respond to cues to press computer keys to win valuable points on a computer game. Next, some of the keys were devalued, that is, they were no longer linked to a valuable outcome and subjects were told not to press them when cued to do so. Yet, the OCD patients continued to habitually press in response to the cue, even after the keys had ceased to be linked to a reward.</p>
<p>The next study attempted to more closely model the development of compulsions as behaviors designed to avoid harmful consequences (as opposed to gain appetitive outcomes), using a shock-avoidance task (<xref ref-type="bibr" rid="CIT0057">Gillan et al., 2014</xref>). Subjects were trained to lever-press in response to a computer signal to avoid a mildly painful electric shock indicated by the signal. After excessive training on the task, the electric wire was obviously disconnected and the subjects instructed not to press in response to the signal. As predicted, however, patients with OCD continued to lever-press to the devalued stimulus that explicitly no longer predicted a shock and did so significantly more than a matched healthy control group (<xref ref-type="bibr" rid="CIT0057">Gillan et al., 2014</xref>). In a subsequent study, this habitual shock-avoidance behavior was directly related to fMRI evidence of hyperactivity in both the vmPFC, during the initial acquisition of the goal-directed avoidance behavior, and in the caudate, during the performance of the habitual avoidance behaviors (<xref ref-type="bibr" rid="CIT0058">Gillan et al., 2015</xref>). In addition, more OCD patients than controls reported experiencing a <italic>premonitory urge</italic> to perform the shock-avoidance habits, the intensity of which correlated with the performance of the habits and with the strength of the fMRI caudate hyperactivity. These findings provide compelling support for the hypothesis that compulsions in OCD result from a shift from goal-directed to habitual behavioral control and are underpinned by changes in neural activity focused around the vmPFC, caudate nucleus, and the associated fronto-striatal neural circuitry.</p>
</sec>
<sec id="s10">
<title>Safety Signaling</title>
<p>The vmPFC plays a complex role in fear learning and safety-signaling and is closely involved in integrating the evaluative processing of environmental cues with flexible behavior. Abnormal vmPFC activation has been implicated in anxiety disorders (<xref ref-type="bibr" rid="CIT0133">Schiller et al., 2008</xref>; <xref ref-type="bibr" rid="CIT0018">Cha et al., 2014</xref>,) as well as in impaired fear retention in OCD (<xref ref-type="bibr" rid="CIT0093">Milad et al., 2013</xref>). Dysfunctional processing within the vmPFC therefore represents a plausible mechanism by which explicit contingency knowledge related to safety and harm is undermined, leading to the failure to flexibly update fear responses and the persistence of rigid, habitual compulsive activity. Further studies in OCD patients are therefore under way to clarify the neuro-psychological relationship between fear and anxiety processing in the vmPFC on the one hand and cognitive flexibility in the caudate nucleus on the other. A recent neuroimaging study of Pavlovian fear reversal found that OCD patients failed to flexibly update fear responses, as measured by skin conductance changes, despite normal initial fear conditioning. This inability to update threat estimation was significantly correlated with vmPFC hyperactivation during early fear learning. The findings suggest that there is an absence of vmPFC safety signaling in OCD that potentially undermines explicit contingency knowledge and that may go some way to explain the link between cognitive inflexibility, fear, and anxiety processing in compulsive disorders such as OCD (<xref ref-type="bibr" rid="CIT0005">Apergis-Schoute et al., 2017</xref>).</p>
</sec>
</sec>
<sec id="s11">
<title>Compulsive-Obsessive Disorder</title>
<p>In the shock avoidance studies by <xref ref-type="bibr" rid="CIT0050">Gillan et al. (2014</xref>, <xref ref-type="bibr" rid="CIT0058">2015</xref>), posthoc explanations for continuing to respond to the devalued stimulus (e.g., “why did you press?”) were described as irrational threat beliefs by many of the OCD patients (e.g., “I thought I might still be shocked”). Like obsessions, these beliefs were directly contradictory to the patients’ explicit knowledge of threat and their ratings of shock expectancy. Thus, in OCD subjects faced with aversive situations, dysfunctional activation of the vmPFC and dorsal striatum may disrupt normal goal-directed behavior, leading to the generation of harm-avoidance habits that readily become compulsive or urge-driven and that may go on to create ego-dystonic, irrational fears (obsessions) with the effect of perpetuating the compulsive behavior. According to this compulsive-obsessive disorder model, the compulsive behaviors of OCD play a key role in ensuring the persistence of the obsessions.</p>
<p>Consistent with this model, behavioral therapy using exposure and response prevention (ERP), representing the standard psychological therapy for OCD (www. NICE.org.uk), requires patients to undergo symptom provocation via exposure to relevant stimuli or situations in order to learn to resist the urge to perform the compulsions. ERP has been found not only to produce a reduction in compulsive responding, but also concurrently causes the <italic>urge</italic> to respond and the associated obsessive thoughts to attenuate (<xref ref-type="bibr" rid="CIT0053">Foa et al., 2005</xref>). Our data suggest that suppressing compulsions, for example using ERP, should remain a key therapeutic intervention in OCRDs and hint that habit reversal therapies (<xref ref-type="bibr" rid="CIT0100">Morris et al., 2013</xref>) that are designed to break habitual associations between exposure-related cues and compulsive responses and that are currently used to treat hair-pulling disorder (<xref ref-type="bibr" rid="CIT0129">Rothbart et al., 2013</xref>) may also have value in OCD, for example by augmenting the clinical response to ERP.</p>
</sec>
<sec id="s12">
<title>Disorders of Compulsivity: A Common Bias toward Learning Habits?</title>
<p>A number of computational modelling techniques (e.g., the two-step sequential discrimination task; <xref ref-type="bibr" rid="CIT0032">Daw et al., 2011</xref>) have been developed to infer the prevailing balance between goal-directed and habitual behavioral control by assessing a person’s decision-making tendencies (respectively, model-based versus model-free). These questionnaires and computational tasks have the added advantage of being readily disseminated on-line and therefore available to test very large numbers of subjects. In one of the earliest studies that applied this methodology to compulsivity, <xref ref-type="bibr" rid="CIT0146">Voon et al. (2015a)</xref> tested a trans-diagnostic group of subjects with diagnoses involving both natural reward (binge eating disorder), artificial reward (methamphetamine/cocaine abuse), and OCD and compared them with healthy controls. The results showed a common bias across all these disorders away from model-based (goal-directed) learning. In addition, the habit formation bias was associated with lower grey matter volumes in the caudate and medial orbitofrontal cortex on structural MRI.</p>
<p>The findings suggested that dysfunction in a neurocomputational mechanism favoring model-free habit learning may underlie the repetitive behaviors that ultimately dominate in diverse disorders involving compulsion. In a further study (<xref ref-type="bibr" rid="CIT0147">Voon et al., 2015b</xref>) that compared performance on the two-step task under conditions of reward and loss, OCD subjects compared with healthy volunteers were less goal orientated (model-based) and more habitual (model-free) to reward outcomes with a shift towards greater model-based and lower habitual choices to loss (punishment) outcomes. These results highlight the importance of motivation for learning processes in OCD and suggest that distinct clinical strategies based on reward valence may be warranted.</p>
<p>Most recently, <xref ref-type="bibr" rid="CIT0060">Gillan et al. (2016b)</xref> applied computational modelling to investigate whether a dimensional approach could better delineate the clinical manifestations of goal-directed learning deficits using large-scale online assessment of psychiatric symptoms and neurocognitive performance in two independent general population samples. Nearly 2000 people completed the online self-report questionnaires measuring decision-making preferences as well as symptoms of various mental health conditions. As expected, people demonstrating reduced goal-directed control on the two-step task (<xref ref-type="bibr" rid="CIT0032">Daw et al., 2011</xref>) also reported higher rates of compulsive symptomatology related to OCD and also eating disorder, impulse control disorder, and addiction symptoms, further demonstrating the generalizability of the deficits across multiple compulsive disorders.</p>
<p>By leveraging an online methodology to collect such a large dataset, <xref ref-type="bibr" rid="CIT0060">Gillan et al. (2016b)</xref> were also able to deal with a key limitation of standard case-control research, the question of specificity. While the demonstration of a degree of generalizability of cognitive deficits across compulsive disorders that are similarly characterized by a loss of control over behavior, alcohol addiction, eating disorders, and impulsivity is of interest, without establishing the specificity of this deficit to this class of symptoms (and not depressive symptoms, for example), the findings are limited. By carrying out a factor analysis on their dataset, Gillan and colleagues identified that the self-report psychopathological data could be neatly fitted into three separate transdiagnostic symptom dimensions: compulsive behavior with intrusive thought, anxious-depression, and social withdrawal. Critically, they found that when the individual disorders (OCD, eating disorder, impulse control disorder, addiction) were replaced with the compulsive factor, the deficits in goal-directed control were captured even more strongly. Moreover, this association was highly specific when compared with the other noncompulsive dimensions of psychopathology. These data indicate that deficits in goal-directed control, conferring vulnerability for developing rigid habits, may have a specific role in driving the compulsive behaviors that characterize diverse disorders such as OCD, eating disorder, substance abuse, and addiction.</p>
</sec>
<sec id="s13">
<title>Integrating Neuropsychological Models with Treatment Models</title>
<p>Based on these and other emerging findings, it is possible to draw inferences about the neuropsychological mechanisms underpinning the response to standard treatments in disorders such as OCD (<xref ref-type="bibr" rid="CIT0059">Gillan et al., 2016a</xref>). Increased stress is known to induce a tendency to form habits (<xref ref-type="bibr" rid="CIT0134">Schwabe and Wolf, 2009</xref>). It has therefore been suggested that SSRIs may act in OCD by restraining anxiety and reducing the effects of punishment, thereby helping the OCD patient to switch from habitual towards goal-directed behavior and indirectly attenuating the need to perform compulsions (<xref ref-type="bibr" rid="CIT0097">Morein-Zamir et al., 2013</xref>). This effect of SSRI could also enhance the capacity to benefit from CBT with ERP (<xref ref-type="bibr" rid="CIT0059">Gillan et al., 2016a</xref>). The finding from a non-randomized study that goal-directed learning under both reward and punishment conditions was enhanced in OCD patients receiving SSRI (<xref ref-type="bibr" rid="CIT0105">Palminteri et al., 2012</xref>) provides some support for this hypothesis. Further support is derived from more recent findings in healthy volunteers that acute tryptophan depletion, which reduces serotonin transmission, induced a shift from goal-directed to habitual responding on a slips-of-action test and also had a deleterious effect on model-based learning (<xref ref-type="bibr" rid="CIT0151">Worbe et al., 2015</xref>, <xref ref-type="bibr" rid="CIT0152">2016</xref>).</p>
<p>However, if the mechanism of effect of SSRI in OCD depended on anxiety reduction, benzodiazepines and other anxiolytics would also be expected to show evidence of efficacy, which they do not. Moreover, SSRIs are at their most efficacious in OCD at dosages higher than is typically recommended for anxiety disorders (<xref ref-type="bibr" rid="CIT0049">Fineberg et al., 2013c</xref>; <xref ref-type="bibr" rid="CIT0136">Skapinakis et al., 2016</xref>). An alternative hypothesis, therefore, proposes that SSRIs exert a therapeutic effect in OCD by bolstering goal-directed behavior through direct pharmacological actions in those areas of cortex implicated in safety signaling and goal-directed control, including the vmPFC and medial orbitofrontal cortex (<xref ref-type="bibr" rid="CIT0042">El Mansari and Blier, 2006</xref>; <xref ref-type="bibr" rid="CIT0058">Gillan et al., 2015</xref>; <xref ref-type="bibr" rid="CIT0146">Voon et al 2015a</xref>). <xref ref-type="bibr" rid="CIT0042">El Mansari and Blier (2006)</xref> reviewed the effects on 5-HT release and the adaptive changes in pre- and postsynaptic 5-HT receptor sensitivity induced by SRI treatment in rodent brain structures involved in OCD, including analogues of the OFC. The time course of increased 5-HT release and terminal 5-HT1D desensitization aligned with the course of the therapeutic response to SRI in OCD. In addition, consistent with the dose-dependent therapeutic effect of SRIs, a greater dose of SRI induced greater reuptake inhibition, which played an essential role in this phenomenon. The authors further hypothesized that the therapeutic effect of SRI-enhanced 5-HT release in the OFC is mediated by the activation of postsynaptic 5-HT2-like receptors. This cortical region is among the most consistently implicated in OCD (<xref ref-type="bibr" rid="CIT0148">Whiteside et al., 2004</xref>) and shares overlapping functional connectivity abnormalities with those seen in addicted individuals at rest (<xref ref-type="bibr" rid="CIT0092">Meunier et al., 2012</xref>).</p>
<p>Antipsychotics are used to treat stereotyped or self-injurious behavior in patients with ASD. It has been proposed that antipsychotics may also work in OCD by reducing habitual or stereotyped behavior patterns. The anti-OCD effect of antipsychotic agents, when co-administered with SSRI, has been shown to positively correlate with the drugs’ inherent dopamine D2 and D3 receptor antagonist affinities (<xref ref-type="bibr" rid="CIT0041">Ducasse et al., 2014</xref>). However, whereas studies in rodents have identified a link between dopamine in the dorsal striatum and the flexible modulation of learnt behavior (<xref ref-type="bibr" rid="CIT0085">Lovinger et al., 2010</xref>; <xref ref-type="bibr" rid="CIT0055">Furlong et al., 2014</xref>), studies of dopamine receptor agonists and antagonists in human models of compulsive behavior have produced ambiguous findings (reviewed in <xref ref-type="bibr" rid="CIT0059">Gillan et al., 2016a</xref>).</p>
<p>ERP for OCD involves repeated exposure to the fear-inducing stimuli that would ordinarily trigger a compulsive response, and resistance to the urge to perform the compulsion, so that the urge eventually dissipates. However, ERP usually involves weeks of practice, few people manage to drop all their compulsions, and about one-half of those with the condition are not helped at all (<xref ref-type="bibr" rid="CIT0121">Reghunandanan et al., 2015b</xref>). The finding that, in OCD, patients may fail to flexibly update threat perception through faulty vmPFC safety signaling (<xref ref-type="bibr" rid="CIT0005">Apergis-Schoute et al., 2017</xref>) may explain some of the difficulties that many experience in extinguishing OCD-related fears and offers exciting new treatment heuristics. The failure to recognize when a feared situation has become safe may explain why people with OCD find ERP so difficult and the treatment takes so long to work. Clinicians may therefore find these results helpful in their discussions with their patients, who could be persuaded of the importance of sticking with the therapy rather than giving up prematurely. This may even explain why co-administration of SSRI with ERP is found to be helpful. In addition, the new findings indicate the need to explore new methods of strengthening attention to safe situations during ERP to enhance fear-extinction, for example, through the use of psychopharmacological, cognitive, or neuromodulation strategies.</p>
<p>Another way in which the efficacy of ERP for OCD can be explained is via the systematic breaking of habitual (stimulus-response) associations between exposure-related cues and compulsive responses, achieved through repeated response-prevention exercises (Gillan et al., 2016). Brain-imaging measures of hyperactivity in the caudate nucleus of OCD patients were found to correlate both with goal-directed deficits and subjective urges to respond habitually (<xref ref-type="bibr" rid="CIT0057">Gillan et al., 2014</xref>). In other studies, caudate abnormalities were found to be remediated when OCD patients respond to ERP (<xref ref-type="bibr" rid="CIT0013">Baxter et al., 1992</xref>; <xref ref-type="bibr" rid="CIT0149">Whiteside et al., 2012</xref>). These results suggest ERP may exert a direct effect on caudate hyperactivity. Abstinence in addiction, which results in a reduction in craving, may also work by breaking stimulus-response associations between cues and drug-taking behavior. However, both ERP and abstinence are experienced as aversive and drop-out rates are high, reflecting the need to develop more clinically acceptable ways to deliver this form of treatment. Moreover, as the habitual behaviors are strengthened with repetition (<xref ref-type="bibr" rid="CIT0140">Tricomi et al., 2009</xref>), OCD and addictions become even more difficult to treat over time, emphasizing the importance of detection and intervention at the earliest stage (<xref ref-type="bibr" rid="CIT0047">Fineberg et al., 2013a</xref>; <xref ref-type="bibr" rid="CIT0059">Gillan et al., 2016a</xref>).</p>
</sec>
</sec>
<sec id="s14">
<title>Conclusions</title>
<p>The data presented serve to highlight the potential of a dimensional, biologically grounded approach to psychiatry research. They suggest that vulnerability to compulsive activity can be predicted by a spectrum of neuropsychological mechanisms, including, inter alia, impaired motor inhibition, cognitive inflexibility (attentional set-shift, reversal learning), and an imbalance in goal-directed vs habit learning. In OCD, abnormal safety signaling may undermine accurate safety learning, resulting in inflexible threat beliefs, with important implications for exposure-based therapies that rely on robust safety memories and future treatment development (<xref ref-type="bibr" rid="CIT0005">Apergis-Schoute et al., 2017</xref>).</p>
<p>Avoidance habits, acting via disrupted goal-directed learning, represent a plausible model of chronic OCD-related compulsivity. Furthermore, emerging evidence implicates disrupted goal-directed learning in an extended group of DSM disorders characterized by compulsive behaviors and intrusive thoughts, and maps with specificity onto a trans-diagnostic compulsive symptom-dimension. Distributed network perturbation associated with these cognitive changes, affecting the prefrontal cortex (vmPFC, lateral PFC), the dorsal striatum (caudate), and the associated neuro-circuitry modulating emotional, cognitive, and motor control, has been identified in OCD. Networked studies investigating multiple disorders under the same conditions, head-to-head, are needed to determine the extent to which these changes overlap with or differentiate other disorders of compulsive behavior. Empirical evidence suggests that the psychopathology of OCRDs becomes more habitual over time. Mega-analysis in OCD suggests that illness-related structural brain changes differ in pediatric and adult cases. Longitudinal studies are now needed to explore the effect of duration of untreated disorder on the mediating neurobiology. These findings would have the potential to inform (1) the development of biomarkers to enable the detection of compulsive disorder at the earliest opportunity, crucially, in children, adolescents, and young adults, before it becomes entrenched, as well as (2) the development of new treatments with novel mechanisms of action designed to strengthen goal-directed behavior and top-down cognitive strategies for controlling urges with better efficacy and tolerability. Agreement on a standardized set of validated clinical measures of compulsivity that could be used trans-diagnostically would represent a rational next step.</p>
</sec>
<sec id="s15">
<title>Statement of Interest</title>
<p>In the past several years, Dr Fineberg has received research support from Lundbeck, Glaxo-SmithKline, European College of Neuropsychopharmacology (ECNP), Servier, Cephalon, Astra Zeneca, Medical Research Council (UK), National Institute for Health Research, Wellcome Foundation, University of Hertfordshire, EU (FP7), and Shire. Dr Fineberg has received honoraria for lectures at scientific meetings from Abbott, Otsuka, Lundbeck, Servier, Astra Zeneca, Jazz pharmaceuticals, Bristol Myers Squibb, UK College of Mental Health Pharmacists, and British Association for Psychopharmacology (BAP). Dr Fineberg has received financial support to attend scientific meetings from RANZCP, Shire, Janssen, Lundbeck, Servier, Novartis, Bristol Myers Squibb, Cephalon, International College of Obsessive-Compulsive Spectrum Disorders, International Society for behavioral Addiction, CINP, IFMAD, ECNP, BAP, World Health Organization, and Royal College of Psychiatrists. Dr Fineberg has received financial royalties for publications from Oxford University Press and payment for editorial duties from Taylor and Francis. Dr Chamberlain consults for Cambridge Cognition and Shire. Dr Trevor Robbins has recently consulted for Cambridge Cognition, Mundipharma, Lundbeck, and Otsuka and has received royalties from Cambridge Cognition for CANTAB, and a research grant from Lundbeck, as well as editorial honoraria from Springer Verlag and Elsevier. Dr Barbara Sahakian consults for Cambridge Cognition, Peak, and Mundipharma and holds a grant from the Wallitt Foundation. She has in the recent past consulted for Lundbeck, Servier, and Otsuka and received grants from Peak and Janssen/JandJ.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>T.W.R. and colleagues (A.A.-S., P.B.) acknowledge financial support for studies on OCD from the Wellcome Trust (grant 104631/Z/14/Z). M.M.V. is supported by a Pinsent-Darwin Studentship in Mental Pathology and a Cambridge Home and European Union Scholarship Scheme studentship. C.M.G. is supported by a fellowship from MQ. Dr Chamberlain’s involvement in this work was funded by a Wellcome Trust Fellowship (110049/Z/15/Z).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>C</given-names></name></person-group>(<year>1982</year>)<article-title>Variations in the sensitivity of instrumental responding to reinforcer devaluation</article-title>. <source/>Q J Exp Psychol<volume>34B</volume>:<fpage>77</fpage>–<lpage>98</lpage>.</mixed-citation>
</ref>
<ref id="CIT0002">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dickinson</surname><given-names>A</given-names></name></person-group>(<year>1981</year>)<article-title>Instrumental responding following reinforcer devaluation</article-title>. <source/>Q J Exp Psychol<volume>33</volume>:<fpage>109</fpage>–<lpage>121</lpage>.</mixed-citation>
</ref>
<ref id="CIT0156">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Afshar</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Akuchekian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mahaky</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zarean</surname><given-names>E</given-names></name></person-group>(<year>2014</year>)<article-title>Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial</article-title>. <source/>J Res Med Sci<volume>19</volume>:<fpage>976</fpage>–<lpage>981</lpage>.<pub-id pub-id-type="pmid">25538783</pub-id></mixed-citation>
</ref>
<ref id="CIT0157">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Afshar</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Roohafza</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mohammad-Beigi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Haghighi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jahangard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Shokouh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sadeghi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hafezian</surname><given-names>H</given-names></name></person-group>(<year>2012</year>)<article-title>N-acetylcysteine add-on treatment in refractory obsessive compulsive disorder: a randomized, double-blind, placebo-controlled trial</article-title>. <source/>J Clin Psychopharmacol<volume>32</volume>:<fpage>797</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">23131885</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>DeLong</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Strick</surname><given-names>PL</given-names></name></person-group>(<year>1986</year>)<article-title>Parallel organization of functionally segregated circuits linking basal ganglia and cortex</article-title>. <source/>Annu Rev Neurosci<volume>9</volume>:<fpage>357</fpage>–<lpage>381</lpage>.<pub-id pub-id-type="pmid">3085570</pub-id></mixed-citation>
</ref>
<ref id="CIT0004">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group>(<year>2013</year>)<source/>Diagnostic and statistical manual of mental disorders. <edition>5th ed</edition>
<publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0005">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Apergis-Schoute</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Fernandez-Egea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2017</year>)<article-title>Neural basis of impaired safety signaling in obsessive compulsive disorder</article-title>. <source/>PNAS<volume>114</volume>:<fpage>3216</fpage>–<lpage>3221</lpage>.<pub-id pub-id-type="pmid">28265059</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Arnsten</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>BJ</given-names></name></person-group>(<year>2011</year>)<article-title>Prefrontal cortical organization and function: implications for externalizing disorders</article-title>. <source/>Biol Psychiatry<volume>69c</volume>:<fpage>1131</fpage>–<lpage>2</lpage>.</mixed-citation>
</ref>
<ref id="CIT0007">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Poldrack</surname><given-names>RA</given-names></name></person-group>(<year>2005</year>)<article-title>The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder</article-title>. <source/>Biol Psychiatry<volume>57</volume>:<fpage>1285</fpage>–<lpage>1292</lpage>.<pub-id pub-id-type="pmid">15950000</pub-id></mixed-citation>
</ref>
<ref id="CIT0008">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Atmaca</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Onalan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yildirim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yuce</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Koc</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Korkmaz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Meri</surname><given-names>O</given-names></name></person-group>(<year>2011</year>)<article-title>Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder</article-title>. <source/>J Anxiety Disord<volume>25</volume>:<fpage>680</fpage>–<lpage>685</lpage>.<pub-id pub-id-type="pmid">21441009</pub-id></mixed-citation>
</ref>
<ref id="CIT0009">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Balleine</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Dickinson</surname><given-names>A</given-names></name></person-group>(<year>1998</year>)<article-title>Goal-directed instrumental action: contingency and incentive learning and their cortical substrates</article-title>. <source/>Neuropharmacology<volume>37</volume>:<fpage>407</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">9704982</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Balleine</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>O’Doherty</surname><given-names>JP</given-names></name></person-group>(<year>2010</year>)<article-title>Human and rodent homologies in action control: corticostriatal determinant of goal-directed and habitual action</article-title>. <source/>Neuropsychopharmacology<volume>35</volume>:<fpage>48</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">19776734</pub-id></mixed-citation>
</ref>
<ref id="CIT0011">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Banca</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Vestergaard</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Philipiak</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Pocinho</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Relvas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Castelo-Branco</surname><given-names>M</given-names></name></person-group>(<year>2015</year>)<article-title>Imbalance in habitual vs goal directed neural systems during symptom provocation in obsessive-compulsive disorder</article-title>. <source/>Brain<fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">25564487</pub-id></mixed-citation>
</ref>
<ref id="CIT0012">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Batistuzzo</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Hoexter</surname><given-names>MQ</given-names></name>, <name name-style="western"><surname>Taub</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gentil</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Cesar</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Joaquim</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>D’Alcante</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>McLaughlin</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Canteras</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Savage</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Norén</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>AC</given-names></name></person-group>(<year>2015</year>)<article-title>Visuospatial memory improvement after gamma ventral capsulotomy in treatment refractory obsessive-compulsive disorder patients</article-title>. <source/>Neuropsychopharmacology<volume>40</volume>:<fpage>1837</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">25645373</pub-id></mixed-citation>
</ref>
<ref id="CIT0013">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Baxter</surname><given-names>LR</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Schwartz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Szuba</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Guze</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Mazziotta</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Alazraki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Selin</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Ferng</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Munford</surname><given-names>P</given-names></name><etal></etal></person-group> (<year>1992</year>)<article-title>Caudate glucose metabolite changes with both drug and behavior therapy for obsessive–compulsive disorder</article-title>. <source/>Arch Gen Psychiatry<volume>49</volume>:<fpage>681</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">1514872</pub-id></mixed-citation>
</ref>
<ref id="CIT0159">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Berlin</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Koran</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Jenike</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Shapira</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chaplin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Pallanti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name></person-group>(<year>2011</year>)<article-title>Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder</article-title>. <source/>J Clin Psychiatry<volume>72</volume>:<fpage>716</fpage>–<lpage>721</lpage>.<pub-id pub-id-type="pmid">20816027</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bloch</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Landeros-Weisenberger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kelmendi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Coric</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bracken</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Leckman</surname><given-names>JF</given-names></name></person-group>(<year>2006</year>)<article-title>A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder</article-title>. <source/>Mol Psychiatry<volume>11</volume>:<fpage>622</fpage>–<lpage>632</lpage>.<pub-id pub-id-type="pmid">16585942</pub-id></mixed-citation>
</ref>
<ref id="CIT0161">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bloch</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Wasylink</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Landeros-Weisenberger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Panza</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Billingslea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Leckman</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Krystal</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Bhagwagar</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sanacora</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pittenger</surname><given-names>C</given-names></name></person-group>(<year>2012</year>)<article-title>Effects of ketamine in treatment-refractory obsessive-compulsive disorder</article-title>. <source/>Biol Psychiatry<volume>72</volume>:<fpage>964</fpage>–<lpage>970</lpage>.<pub-id pub-id-type="pmid">22784486</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Boedhoe</surname><given-names>PS</given-names></name><etal></etal></person-group> (<year>2017</year>)<article-title>Distinct subcortical volume alterations in pediatric and adult OCD: a worldwide meta- and mega-analysis</article-title>. <source/>Am J Psychiatry<volume>174</volume>:<fpage>60</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">27609241</pub-id></mixed-citation>
</ref>
<ref id="CIT0016">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bourne</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Eckhardt</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Sheth</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Eskandar</surname><given-names>EN</given-names></name></person-group>(<year>2012</year>)<article-title>Mechanisms of deep brain stimulation in for obsessive compulsive disorder: effects upon cells and circuits</article-title>. <source/>Front Integr Neurosci<volume>14</volume>:<fpage>6</fpage>–<lpage>29</lpage>.</mixed-citation>
</ref>
<ref id="CIT0017">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brody</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>JM</given-names></name></person-group>(<year>1998</year>)<article-title>FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder</article-title>. <source/>Psychiat Res<volume>84</volume>:<fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="CIT0162">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bruno</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Pandolfo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mallamace</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Abenavoli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Di Nardo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>D’Arrigo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Spina</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zoccali</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Muscatello</surname><given-names>MR</given-names></name></person-group>(<year>2012</year>)<article-title>Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo controlled study</article-title>. <source/>J Psychopharmacol<volume>26</volume>:<fpage>1456</fpage>–<lpage>1462</lpage>.<pub-id pub-id-type="pmid">22351381</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cha</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Dedora</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Hajcak</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mujica-Parodi</surname><given-names>LR</given-names></name></person-group>(<year>2014</year>)<article-title>Circuit-wide structural and functional measures predict ventromedial prefrontal cortex fear generalization: implications for generalized anxiety disorder</article-title>. <source/>J Neurosci<volume>34</volume>:<fpage>4043</fpage>–<lpage>4053</lpage>.<pub-id pub-id-type="pmid">24623781</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>del Campo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dowson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group> (<year>2007a</year>) <article-title>Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder</article-title>. <source/>Biol Psychiatry<volume>62</volume>:<fpage>977</fpage>–<lpage>984</lpage>.<pub-id pub-id-type="pmid">17644072</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Blackwell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group> (<year>2006a</year>) <article-title>Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania</article-title>. <source/>Am J Psychiatry<volume>163</volume>:<fpage>1282</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">16816237</pub-id></mixed-citation>
</ref>
<ref id="CIT0021">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Blackwell</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group> (<year>2007b</year>) <article-title>Impaired cognitive function and motor inhibition in first degree relatives of OCD patients: on the trail of endophenotypes</article-title>. <source/>Am J Psychiatry<volume>164</volume>:<fpage>335</fpage>–<lpage>338</lpage>.<pub-id pub-id-type="pmid">17267798</pub-id></mixed-citation>
</ref>
<ref id="CIT0022">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>LA</given-names></name></person-group>(<year>2009</year>)<article-title>Endophenotypes of obsessive-collusive disorder rational, evidence and future potential</article-title>. <source/>Expert Rev Neurother<volume>9</volume>:<fpage>1133</fpage>–<lpage>1146</lpage>.<pub-id pub-id-type="pmid">19673603</pub-id></mixed-citation>
</ref>
<ref id="CIT0023">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Hampshire</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Suckling</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>del Campo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Aitken</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group>(<year>2008</year>)<article-title>Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives</article-title>. <source/>Science<volume>321</volume>:<fpage>421</fpage>–<lpage>422</lpage>.<pub-id pub-id-type="pmid">18635808</pub-id></mixed-citation>
</ref>
<ref id="CIT0024">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Blackwell</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group> (<year>2006b</year>) <article-title>Neurochemical modulation of response inhibition and probabilistic learning in humans</article-title>. <source/>Science<volume>311</volume>:<fpage>861</fpage>–<lpage>863</lpage>.<pub-id pub-id-type="pmid">16469930</pub-id></mixed-citation>
</ref>
<ref id="CIT0025">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Odlaug</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Boulougouris</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name></person-group>(<year>2009</year>)<article-title>Trichotillomania: neurobiology and treatment</article-title>. <source/>Neurosci Biobehav Rev<volume>33</volume>:<fpage>831</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">19428495</pub-id></mixed-citation>
</ref>
<ref id="CIT0026">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2013</year>)<article-title>Noradrenergic modulation of cognition: therapeutic implications</article-title>. <source/>J Psychopharmacol<volume>27</volume>:<fpage>694</fpage>–<lpage>718</lpage>.<pub-id pub-id-type="pmid">23518815</pub-id></mixed-citation>
</ref>
<ref id="CIT0027">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Roiser</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Cool</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rubinsztein</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Sahakain</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group> (<year>2005a</year>) <article-title>Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity</article-title>. <source/>Psychopharmacology<volume>182</volume>:<fpage>570</fpage>–<lpage>578</lpage>.<pub-id pub-id-type="pmid">16163530</pub-id></mixed-citation>
</ref>
<ref id="CIT0028">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Crofts</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Dalley</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>AC</given-names></name></person-group> (<year>2005b</year>) <article-title>Prefrontal serotonin depletion affects reversal learning but not attentional set shifting</article-title>. <source/>J Neurosci<volume>25</volume>:<fpage>532</fpage>–<lpage>538</lpage>.<pub-id pub-id-type="pmid">15647499</pub-id></mixed-citation>
</ref>
<ref id="CIT0158">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>DLC</given-names></name>, <name name-style="western"><surname>Diniz</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Requena</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Joaquim</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Pittenger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bloch</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>RG</given-names></name></person-group>(<year>2017</year>)<article-title>Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder</article-title>. <source/>J Clin Psychiatry<volume>78</volume>(<issue>7</issue>):<fpage>e766</fpage>–<lpage>e773</lpage>. Retrieved from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28617566">https://www.ncbi.nlm.nih.gov/pubmed/28617566</ext-link>.<pub-id pub-id-type="pmid">28617566</pub-id></mixed-citation>
</ref>
<ref id="CIT0029">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cummings</surname><given-names>JL</given-names></name></person-group>(<year>1993</year>)<article-title>Frontal-subcortical circuits and human behavior</article-title>. <source/>Arch Neurol<volume>50</volume>:<fpage>873</fpage>–<lpage>880</lpage>.<pub-id pub-id-type="pmid">8352676</pub-id></mixed-citation>
</ref>
<ref id="CIT0030">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dalley</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Everitt</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2011</year>)<article-title>Impulsivity, compulsivity, and top-down cognitive control</article-title>. <source/>Neuron<volume>69</volume>:<fpage>681</fpage>–<lpage>694</lpage>.</mixed-citation>
</ref>
<ref id="CIT0031">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Darrow</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Hirschtritt</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Illmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Osiecki</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Grados</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sandor</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dion</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>King</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pauls</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Budman</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Cath</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lyon</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McGrath</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Delucchi</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Scharf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>CA</given-names></name></person-group>;<comment> Tourette Syndrome Association International Consortium for Genetics</comment>(<year>2016</year>)<article-title>Identificationof two heritable cross disorder endophenotypes for Tourette syndrome</article-title>. <source/>Am J Psychiatry<comment>dx.doi.org/ 10.1176/appi.ajp.2016.16020240</comment>.</mixed-citation>
</ref>
<ref id="CIT0032">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Daw</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Gershman</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Seymour</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dayan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dolan</surname><given-names>RJ</given-names></name></person-group>(<year>2011</year>)<article-title>Model-based influences on humans’ choices and striatal prediction errors</article-title>. <source/>Neuron<volume>69</volume>:<fpage>1204</fpage>–<lpage>1215</lpage>.<pub-id pub-id-type="pmid">21435563</pub-id></mixed-citation>
</ref>
<ref id="CIT0033">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dell’Osso</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hadley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Chaplin</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name></person-group>(<year>2008</year>)<article-title>Escitalopram in the treatment of impulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase</article-title>. <source/>J Clin Psychiatry<volume>69</volume>:<fpage>452</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">18312057</pub-id></mixed-citation>
</ref>
<ref id="CIT0034">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dell’Osso</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Benatti</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Buoli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Altamura</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Marazziti</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pallanti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nicolini</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Van Ameringen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lochner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hranov</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Karamustafalioglu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Hranov</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Menchon</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Zohar</surname><given-names>J</given-names></name></person-group>(<year>2013</year>)<article-title>The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of obsessive compulsive spectrum disorders (ICOCS) ICOCS group</article-title>. <source/>Eur Neuropsychopharmacol<volume>23</volume>:<fpage>865</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">23791074</pub-id></mixed-citation>
</ref>
<ref id="CIT0035">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Denys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>de Vries E Cath</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Figee</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vulink</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>van der Doef</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Boellaard</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Westenberg</surname><given-names>H</given-names></name>, <name name-style="western"><surname>van Balkom</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lammertsma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van Berckel</surname><given-names>B</given-names></name></person-group>(<year>2013</year>)<article-title>Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder</article-title>. <source/>Eur Neuropsychopharmacol<volume>23</volume>:<fpage>1423</fpage>–<lpage>1431</lpage>.<pub-id pub-id-type="pmid">23876376</pub-id></mixed-citation>
</ref>
<ref id="CIT0036">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>De Sousa</surname><given-names>A</given-names></name></person-group>(<year>2008</year>)<article-title>An open-label pilot study of naltrexone in childhood-onset trichotillomania</article-title>. <source/>J Child Adolesc Psychopharmacol<volume>18</volume>:<fpage>30</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">18294086</pub-id></mixed-citation>
</ref>
<ref id="CIT0037">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Vries</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cath</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hoogendoorn</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>van Oppen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Glas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>O</given-names></name>, <name name-style="western"><surname>van Balkom</surname><given-names>A</given-names></name></person-group>(<year>2016</year>)<article-title>Tic-relatedvstic-freeobsessive-compulsivedisorder: clinical picture and 2-year natural course</article-title>. <source/>J Clin Psychiatry<volume>77</volume>:<fpage>1240</fpage>–<lpage>1247</lpage>.</mixed-citation>
</ref>
<ref id="CIT0038">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dickinson</surname><given-names>A</given-names></name></person-group>(<year>2009</year>)<article-title>Associative theories of goal-directed behavior: a case for animal-human translational models</article-title>. <source/>Psychol Res<volume>73</volume>:<fpage>463</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">19350272</pub-id></mixed-citation>
</ref>
<ref id="CIT0039">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Wit</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>de Vries</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>van der Werf</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Cath</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Heslenfeld</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>van Balkom</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>OA</given-names></name></person-group>(<year>2012</year>)<article-title>Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder</article-title>. <source/>Am J Psychiatry<volume>169</volume>:<fpage>1100</fpage>–<lpage>1108</lpage>.<pub-id pub-id-type="pmid">23032388</pub-id></mixed-citation>
</ref>
<ref id="CIT0040">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dougherty</surname><given-names>DD</given-names></name><etal></etal></person-group> (<year>2015</year>)<article-title>A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression</article-title>. <source/>Biol Psychiatry<volume>78</volume>:<fpage>240</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">25726497</pub-id></mixed-citation>
</ref>
<ref id="CIT0041">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ducasse</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Boyer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Loundou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Macgregor</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Micoulaud-Franchi</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Courtet</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Abbar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Leboyer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fond</surname><given-names>G</given-names></name></person-group>(<year>2014</year>)<article-title>D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis</article-title>. <source/>Psychopharmacology<volume>231</volume>:<fpage>3765</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">24599398</pub-id></mixed-citation>
</ref>
<ref id="CIT0042">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>El Mansari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Blier</surname><given-names>P</given-names></name></person-group>(<year>2006</year>)<article-title>Mechanisms of action of current and potential pharmacotherapies of obsessive–compulsive disorder</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry<volume>30</volume>:<fpage>362</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">16427729</pub-id></mixed-citation>
</ref>
<ref id="CIT0043">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Everitt</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2005</year>)<article-title>Neural systems of reinforcement for drug addiction: from actions to habits to compulsion</article-title>. <source/>Nat Neuroscience<volume>8</volume>:<fpage>1481</fpage>–<lpage>1489</lpage>.<pub-id pub-id-type="pmid">16251991</pub-id></mixed-citation>
</ref>
<ref id="CIT0044">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Figee</surname><given-names>M</given-names></name><etal></etal></person-group> (<year>2013</year>)<article-title>Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder</article-title>. <source/>Nat Neuroscience<volume>16</volume>:<fpage>386</fpage>–<lpage>387</lpage>.<pub-id pub-id-type="pmid">23434914</pub-id></mixed-citation>
</ref>
<ref id="CIT0045">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Sareen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sookman</surname><given-names>D</given-names></name></person-group>(<year>2015</year>)<article-title>Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults</article-title>. <source/>Psychiatry Res<volume>227</volume>:<fpage>114</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">25681005</pub-id></mixed-citation>
</ref>
<ref id="CIT0046">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Potenza</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Berlin</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bechara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name></person-group>(<year>2010</year>)<article-title>Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review</article-title>. <source/>Neuropsychopharmacology<volume>35</volume>:<fpage>591</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">19940844</pub-id></mixed-citation>
</ref>
<ref id="CIT0047">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Baldwin</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Menchon</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Denys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Grünblatt</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pallanti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Zohar</surname><given-names>J</given-names></name></person-group> (<year>2013a</year>) <article-title>The obsessive compulsive and related disorders research network. Manifesto for a European research network into obsessive-compulsive and related disorders</article-title>. <source/>Eur Neuropsychopharmacol<volume>23</volume>:<fpage>561</fpage>–<lpage>568</lpage>.<pub-id pub-id-type="pmid">22796228</pub-id></mixed-citation>
</ref>
<ref id="CIT0164">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Hengartner</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Bergbaum</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Gale</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gamma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ajdacic-Gross</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Rössler</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Angst</surname><given-names>J</given-names></name></person-group> (<year>2013b</year>). <article-title>A Prospective Population-Based Cohort Study Of The Prevalence, Incidence And Impact Of Obsessive-Compulsive Symptomatology</article-title>. <source/>Int J Psychiatry Clin Pract<volume>17</volume>(<issue>3</issue>):<fpage>170</fpage>–<lpage>178</lpage>.<pub-id pub-id-type="pmid">23205952</pub-id></mixed-citation>
</ref>
<ref id="CIT0049">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pampaloni</surname><given-names>I</given-names></name></person-group> (<year>2013c</year>) <article-title>Pharmacotherapy of obsessive–compulsive disorder: evidence-based treatment and beyond</article-title>. <source/>Aust NZ J Psychiatry<volume>47</volume>:<fpage>121</fpage>–<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="CIT0050">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Goudriaan</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Vanderschuren</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Shekar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gorwood</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Denys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Moeller</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Potenza</surname><given-names>MN</given-names></name></person-group>(<year>2014</year>)<article-title>New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity</article-title>. <source/>CNS Spectr<volume>19</volume>:<fpage>69</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">24512640</pub-id></mixed-citation>
</ref>
<ref id="CIT0051">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>de Koenigswarter</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kolli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jefferies-Sewell</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hranov</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>K</given-names></name></person-group>(<year>2015</year>)<article-title>The neuropsychology of obsessive-compulsive personality disorder: a new analysis</article-title>. <source/>CNS Spectr<volume>17</volume>:<fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="CIT0052">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Apergis-Schoute</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Vaghi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Banca</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Cinosi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2016</year>)<article-title>Mapping compulsivity: cognitive domains, neural circuitry and treatment</article-title>. <source/>Int J Neuropsychopharmacology<volume>19</volume> (<issue>Suppl 1</issue>):<fpage>47</fpage>.</mixed-citation>
</ref>
<ref id="CIT0053">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Foa</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Liebowitz</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Kozak</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Campeas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Franklin</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Huppert</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Kjernisted</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rowan</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>X</given-names></name></person-group>(<year>2005</year>)<article-title>Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine and their combination in the treatment of obsessive–compulsive disorder</article-title>. <source/>Am J Psychiatry<volume>162</volume>:<fpage>151</fpage>–<lpage>161</lpage>.<pub-id pub-id-type="pmid">15625214</pub-id></mixed-citation>
</ref>
<ref id="CIT0054">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Frost</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Steketee</surname><given-names>G</given-names></name></person-group>(<year>2010</year>)<source/>Stuff: compulsive hoarding and the meaning of things. <publisher-loc>Boston and New York</publisher-loc>: <publisher-name>Houghton Mifflin Harcourt</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0055">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Furlong</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Jayaweera</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Balleine</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Corbit</surname><given-names>LH</given-names></name></person-group>(<year>2014</year>)<article-title>Binge-like consumption of a palatable food accelerates habitual control of behavior and is dependent on activation of the dorsolateral striatum</article-title>. <source/>J Neurosci<volume>34</volume>:<fpage>5012</fpage>–<lpage>5022</lpage>.<pub-id pub-id-type="pmid">24695718</pub-id></mixed-citation>
</ref>
<ref id="CIT0163">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ghaleiha</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Entezari</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Modabbernia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Najand</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Askari</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tabrizi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ashrafi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hajiaghaee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Akhondzadeh</surname><given-names>S</given-names></name></person-group>(<year>2013</year>)<article-title>Memantine add-on in moderate to severe obsessive compulsive disorder: randomized double-blind placebo-controlled study</article-title>. <source/>J Psychiatr Res<volume>47</volume>:<fpage>175</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">23063327</pub-id></mixed-citation>
</ref>
<ref id="CIT0056">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Papmeyer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name></person-group>(<year>2011</year>)<article-title>Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder</article-title>. <source/>Am J Psychiatry<volume>168</volume>:<fpage>718</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">21572165</pub-id></mixed-citation>
</ref>
<ref id="CIT0057">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Urcelay</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Sule</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Apergis-Schoute</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2014</year>)<article-title>Enhanced avoidance habits in obsessive-compulsive disorder</article-title>. <source/>Biol Psychiatry<volume>75</volume>:<fpage>631</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">23510580</pub-id></mixed-citation>
</ref>
<ref id="CIT0058">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Apergis-Schoute</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Urcelay</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Sule</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2015</year>)<article-title>functional neuroimaging of avoidance habits in obsessive-compulsive disorder</article-title>. <source/>Am J Psychiatry<volume>172</volume>:<fpage>284</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">25526600</pub-id></mixed-citation>
</ref>
<ref id="CIT0059">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>O</given-names></name>, <name name-style="western"><surname>van Wingen</surname><given-names>G</given-names></name></person-group> (<year>2016a</year>) <article-title>The role of habit in compulsivity</article-title>. <source/>Eur Neuropsychopharmacol<volume>26</volume>:<fpage>828</fpage>–<lpage>840</lpage>.<pub-id pub-id-type="pmid">26774661</pub-id></mixed-citation>
</ref>
<ref id="CIT0060">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Kosinski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Whelan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Phelps</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Daw</surname><given-names>ND</given-names></name></person-group> (<year>2016b</year>) <article-title>Characterizing a psychiatric symptom dimension related to deficits in goal-directed control</article-title>. <source/>eLifescience<volume>5</volume>:<fpage>1</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="CIT0061">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gottesman</surname><given-names>II</given-names></name>, <name name-style="western"><surname>Gould</surname><given-names>TD</given-names></name></person-group>(<year>2003</year>)<article-title>The endophenotype concept in psychiatry: etymology and strategic intentions</article-title>. <source/>Am J Psychiatry<volume>160</volume>:<fpage>636</fpage>–<lpage>645</lpage>.<pub-id pub-id-type="pmid">12668349</pub-id></mixed-citation>
</ref>
<ref id="CIT0062">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Odlaug</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name></person-group>(<year>2009</year>)<article-title>N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study</article-title>. <source/>Arch Gen Psychiatry<volume>66</volume>:<fpage>756</fpage>–<lpage>763</lpage>.<pub-id pub-id-type="pmid">19581567</pub-id></mixed-citation>
</ref>
<ref id="CIT0063">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Odlaug</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name></person-group>(<year>2010</year>)<article-title>A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response</article-title>. <source/>J Clin Psychopharmacol<volume>30</volume>:<fpage>396</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="pmid">20531220</pub-id></mixed-citation>
</ref>
<ref id="CIT0064">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Odlaug</surname><given-names>B</given-names></name></person-group> (<year>2014a</year>) <source/>Clinical guide to obsessive compulsive and related disorders. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0065">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Odlaug</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name></person-group> (<year>2014b</year>) <article-title>The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study</article-title>. <source/>J Clin Psychopharmacol<volume>34</volume>:<fpage>134</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">24145220</pub-id></mixed-citation>
</ref>
<ref id="CIT0066">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Graybiel</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name></person-group>(<year>2000</year>)<article-title>Toward a neurobiology of obsessive-compulsive disorder</article-title>. <source/>Neuron<volume>28</volume>:<fpage>343</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">11144344</pub-id></mixed-citation>
</ref>
<ref id="CIT0067">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Groenewegen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Uylings</surname><given-names>HB</given-names></name></person-group>(<year>2000</year>)<article-title>The prefrontal cortex and the integration of sensory, limbic and autonomic information</article-title>. <source/>Prog Brain Res<volume>126</volume>:<fpage>3</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">11105636</pub-id></mixed-citation>
</ref>
<ref id="CIT0068">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Groenewegen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Cath</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Voorn</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>DJ</given-names></name></person-group>(<year>2003</year>)<article-title>Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette’s syndrome? A neuronal circuit approach</article-title>. <source/>Brain Dev<volume>25</volume>:<fpage>3</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">12536026</pub-id></mixed-citation>
</ref>
<ref id="CIT0165">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Haghighi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jahangard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mohammad-Beigi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bajoghli</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hafezian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rahimi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Afshar</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Holsboer-Trachsler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Brand</surname><given-names>S</given-names></name></person-group>(<year>2013</year>)<article-title>In a double-blind, randomized and placebo controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)</article-title>. <source/>Psychopharmacology (Berl)<volume>228</volume>:<fpage>633</fpage>–<lpage>640</lpage>.<pub-id pub-id-type="pmid">23525525</pub-id></mixed-citation>
</ref>
<ref id="CIT0069">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Haro</surname><given-names>JM</given-names></name><etal></etal></person-group> (<year>2014</year>)<article-title>ROAMER: roadmap for mental health research in Europe</article-title>. <source/>Int J Methods Psychiatry Res<volume>23</volume>:<fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="CIT0070">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hellriegel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Barber</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wikramanayake</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Mandy</surname><given-names>W</given-names></name></person-group>(<year>2016</year>)<article-title>Is “not just right experience” (NJRE) in obsessive-compulsive disorder part of an autistic phenotype</article-title>?<source/>CNS Spectr<volume>11</volume>:<fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="CIT0071">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hesse</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stengler</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Regenthal</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Patt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Franke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Knupfer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Luthardt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lobsien</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Heinke</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Brust</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hegel</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Sabri</surname><given-names>O</given-names></name></person-group>(<year>2011</year>)<article-title>The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disoder</article-title>. <source/>Int J Neuropsychopharmacol<volume>14</volume>:<fpage>606</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">21232166</pub-id></mixed-citation>
</ref>
<ref id="CIT0072">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hoexter</surname><given-names>MQ</given-names></name>, <name name-style="western"><surname>Dougherty</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>D’Alcante</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Duran</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Diniz</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Batistuzzo</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bresnan</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Busatto</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name></person-group>(<year>2013</year>)<article-title>Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioraltherapyinobsessive-compulsivedisorder</article-title>.<source/>Eur Neuropsychopharm<volume>23</volume>:<fpage>569</fpage>–<lpage>580</lpage>.</mixed-citation>
</ref>
<ref id="CIT0073">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Novotny</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hanratty</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yaffe</surname><given-names>R</given-names></name>, <name name-style="western"><surname>DeCaria</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Aronowitz</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Mosovich</surname><given-names>S</given-names></name></person-group>(<year>2003</year>)<article-title>Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders</article-title>. <source/>Neuropsychopharmacology<volume>28</volume>:<fpage>193</fpage>–<lpage>198</lpage>.<pub-id pub-id-type="pmid">12496956</pub-id></mixed-citation>
</ref>
<ref id="CIT0074">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Doernberg</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Waterman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Soreni</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name></person-group>(<year>2016</year>)<article-title>The cost and impact of compulsivity: a research perspective</article-title>. <source/>Eur Neuropsychopharmacol<volume>26</volume>:<fpage>800</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="pmid">27235690</pub-id></mixed-citation>
</ref>
<ref id="CIT0075">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hugo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>van Heerden</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zungu-Dirwayi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group>(<year>1999</year>)<article-title>Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions</article-title>. <source/>Depress Anxiety<volume>10</volume>:<fpage>129</fpage>–<lpage>136</lpage>.<pub-id pub-id-type="pmid">10604087</pub-id></mixed-citation>
</ref>
<ref id="CIT0076">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Insel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cuthbert</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Garvey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heinssen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pine</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Quin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sanislow</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name></person-group>(<year>2010</year>)<article-title>Research domain criteria (RDoC): toward a new classification framework for research on mental disorders</article-title>. <source/>Am J Psychiatry<volume>167</volume>:<fpage>748</fpage>–<lpage>751</lpage>.<pub-id pub-id-type="pmid">20595427</pub-id></mixed-citation>
</ref>
<ref id="CIT0166">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Insel</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Guttmacher</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>DL</given-names></name></person-group>(<year>1983</year>)<article-title>D-amphetamine in obsessive-compulsive disorder</article-title>. <source/>Psychopharmacology (Berl)<volume>80</volume>:<fpage>231</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">6412267</pub-id></mixed-citation>
</ref>
<ref id="CIT0077">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ioannidis</surname><given-names>K</given-names></name><etal></etal></person-group> (<year>2016</year>)<article-title>Problematic internet use (PIU): associations with the impulsive-compulsive spectrum</article-title>. <source/>J Psychiatr Res<volume>83</volume>:<fpage>94</fpage>–<lpage>102</lpage>.<pub-id pub-id-type="pmid">27580487</pub-id></mixed-citation>
</ref>
<ref id="CIT0078">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jefferies-Sewell</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>K</given-names></name></person-group>(<year>2016</year>)<article-title>Cognitive dysfunction in body dysmorphic disorder: new implications for nosological systems and neurobiological models</article-title>. <source/>CNS Spectr<volume>30</volume>:<fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="CIT0167">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Joffe</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Swinson</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Levitt</surname><given-names>AJ</given-names></name></person-group>(<year>1991</year>)<article-title>Acute psychostimulant challenge in primary obsessive-compulsive disorder</article-title>. <source/>J Clin Psychopharmacol<volume>11</volume>:<fpage>237</fpage>–<lpage>241</lpage>.<pub-id pub-id-type="pmid">1680885</pub-id></mixed-citation>
</ref>
<ref id="CIT0168">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khalkhali</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aram</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zarrabi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kafie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heidarzadeh</surname><given-names>A</given-names></name></person-group>(<year>2016</year>)<article-title>Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial</article-title>. <source/>Iran J Psychiatry<volume>11</volume>:<fpage>104</fpage>–<lpage>114</lpage>.<pub-id pub-id-type="pmid">27437007</pub-id></mixed-citation>
</ref>
<ref id="CIT0079">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Klanker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Feenstra</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Denys</surname><given-names>D</given-names></name></person-group>(<year>2013</year>)<article-title>Dopaminergic control of cognitive flexibility in humans and animals</article-title>. <source/>Front Neurosci<volume>5</volume>:<fpage>7</fpage>–<lpage>201</lpage>.</mixed-citation>
</ref>
<ref id="CIT0080">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kolevzon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mathewson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name></person-group>(<year>2006</year>)<article-title>Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability</article-title>. <source/>J Clin Psychiatry<volume>67</volume>:<fpage>407</fpage>–<lpage>414</lpage>.<pub-id pub-id-type="pmid">16649827</pub-id></mixed-citation>
</ref>
<ref id="CIT0169">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koran</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Gamel</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Choung</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Aboujaoude</surname><given-names>EN</given-names></name></person-group> (<year>2005a</year>) <article-title>Mirtazapine for obsessive-compulsive disorder: An open trial followed by double-blind discontinuation</article-title>. <source/>Journal of Clinical Psychiatry<volume>66</volume>:<fpage>515</fpage>–<lpage>520</lpage>.<pub-id pub-id-type="pmid">15816795</pub-id></mixed-citation>
</ref>
<ref id="CIT0170">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koran</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Aboujaoude</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bullock</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Franz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gamel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>M</given-names></name></person-group> (<year>2005b</year>) <article-title>Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder</article-title>. <source/>J Clin Psychiatry<volume>66</volume>(<issue>3</issue>):<fpage>353</fpage>–<lpage>359</lpage>.<pub-id pub-id-type="pmid">15766302</pub-id></mixed-citation>
</ref>
<ref id="CIT0081">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lervolino</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Alessandra</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Perroud</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fullana</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Guipponi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cherkas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Collier</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name></person-group>(<year>2009</year>)<article-title>Prevalence and heritability of compulsive hoarding: a twin study</article-title>. <source/>Am J Psychiatry<volume>166</volume>:<fpage>1156</fpage>–<lpage>1161</lpage>.<pub-id pub-id-type="pmid">19687130</pub-id></mixed-citation>
</ref>
<ref id="CIT0082">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Horner</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Bisby</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>N</given-names></name></person-group>(<year>2015</year>)<article-title>Medial prefrontal cortex: adding value to imagined scenarios</article-title>. <source/>J Cogn Neurosci<volume>27</volume>:<fpage>1957</fpage>–<lpage>1967</lpage>.<pub-id pub-id-type="pmid">26042501</pub-id></mixed-citation>
</ref>
<ref id="CIT0083">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>A</given-names></name><etal></etal></person-group> (<year>2014</year>)<article-title>Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial</article-title>. <source/>JAMA Psychiatry<volume>71</volume>:<fpage>1066</fpage>–<lpage>1076</lpage>.<pub-id pub-id-type="pmid">25054836</pub-id></mixed-citation>
</ref>
<ref id="CIT0084">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Norén</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name></person-group>(<year>2015</year>)<source/>JAMA Psychiatry<volume>72</volume>:<fpage>1258</fpage>.<pub-id pub-id-type="pmid">26509602</pub-id></mixed-citation>
</ref>
<ref id="CIT0085">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lovinger</surname><given-names>DM</given-names></name></person-group>(<year>2010</year>)<article-title>Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum</article-title>. <source/>Neuropharmacology<volume>58</volume>:<fpage>951</fpage>–<lpage>961</lpage>.<pub-id pub-id-type="pmid">20096294</pub-id></mixed-citation>
</ref>
<ref id="CIT0086">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marras</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Pallanti</surname><given-names>S</given-names></name></person-group>(<year>2016</year>)<article-title>Obsessive compulsive and related disorders: comparing DSM-5 and ICD-11</article-title>. <source/>CNS Spectr<volume>12</volume>:<fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="CIT0087">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>OA</given-names></name></person-group>(<year>2006</year>)<article-title>Common and distinct neural correlates of obessive-compulsive and related disorders</article-title>. <source/>Psychiatr Clin North Am<volume>29</volume>:<fpage>391</fpage>–<lpage>410</lpage>.<pub-id pub-id-type="pmid">16650715</pub-id></mixed-citation>
</ref>
<ref id="CIT0088">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ichise</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ando</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ikoma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kosaka</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Arakawa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fujimura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ota</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fukui</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Suhara</surname><given-names>T</given-names></name></person-group>(<year>2010</year>)<article-title>Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C] DASB PET study</article-title>. <source/>Neuroimage<volume>49</volume>:<fpage>121</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">19660554</pub-id></mixed-citation>
</ref>
<ref id="CIT0089">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McGuire</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Ung</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Selles</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Rahman</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Lewin</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Storch</surname><given-names>EA</given-names></name></person-group>(<year>2014</year>)<article-title>Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors</article-title>. <source/>J Psychiatr Res<volume>58</volume>:<fpage>76</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">25108618</pub-id></mixed-citation>
</ref>
<ref id="CIT0090">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Menzies</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Achard</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>del Campo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Trevor</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>Ed</given-names></name></person-group>(<year>2007</year>)<article-title>Neurocognitive endophenotypes of obsessive-compulsive disorder</article-title>. <source/>Brain<volume>130</volume>:<fpage>3223</fpage>–<lpage>3236</lpage>.<pub-id pub-id-type="pmid">17855376</pub-id></mixed-citation>
</ref>
<ref id="CIT0091">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Menzies</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Thelen</surname><given-names>Sm</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name></person-group>(<year>2008</year>)<article-title>Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited</article-title>. <source/>Neurosci Biobehav Rev<volume>32</volume>:<fpage>525</fpage>–<lpage>549</lpage>.<pub-id pub-id-type="pmid">18061263</pub-id></mixed-citation>
</ref>
<ref id="CIT0092">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meunier</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ersche</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Fornito</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Merlo-Pich</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name></person-group>(<year>2012</year>)<article-title>Brain functional connectivity in stimulant drug dependence and obsessive–compulsive disorder</article-title>. <source/>Neuroimage<volume>59</volume>:<fpage>1461</fpage>–<lpage>1468</lpage>.<pub-id pub-id-type="pmid">21871569</pub-id></mixed-citation>
</ref>
<ref id="CIT0093">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milad</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Furtak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Keshaviah</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Im</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Falkenstein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jenike</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rauch</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wilhelm</surname><given-names>S</given-names></name></person-group>(<year>2013</year>)<article-title>Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit</article-title>. <source/>JAMA Psychiatry<volume>70</volume>:<fpage>608</fpage>–<lpage>618</lpage>.<pub-id pub-id-type="pmid">23740049</pub-id></mixed-citation>
</ref>
<ref id="CIT0094">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milad</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name></person-group>(<year>2012</year>)<article-title>Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways</article-title>. <source/>Trends Cogn Sci<volume>16</volume>:<fpage>43</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">22138231</pub-id></mixed-citation>
</ref>
<ref id="CIT0095">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Monzani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rijsdijk</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Anson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Iervolino</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Cherkas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spector</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name></person-group>(<year>2012</year>)<article-title>A twin study of body dysmorphic concerns</article-title>. <source/>Psychol Med<volume>42</volume>:<fpage>1949</fpage>–<lpage>1955</lpage>.<pub-id pub-id-type="pmid">22126745</pub-id></mixed-citation>
</ref>
<ref id="CIT0096">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group>(<year>2010</year>). <article-title>Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype</article-title>?<source/>Psychol Med<volume>40</volume>:<fpage>263</fpage>–<lpage>272</lpage>.<pub-id pub-id-type="pmid">19573261</pub-id></mixed-citation>
</ref>
<ref id="CIT0097">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Papmeyer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Crockett</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2013</year>)<article-title>Punishment promotes response control deficits in obsessive–compulsive disorder: evidence from a motivational go/no-go task</article-title>. <source/>Psychol Med<volume>43</volume>:<fpage>391</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">22578546</pub-id></mixed-citation>
</ref>
<ref id="CIT0098">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Morein-Zamir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pamperer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pertusa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2014</year>)<article-title>The profile of executive function in OCD hoarders and hoarding disorder</article-title>. <source/>Psychiatry Res<volume>215</volume>:<fpage>659</fpage>–<lpage>667</lpage>.<pub-id pub-id-type="pmid">24467873</pub-id></mixed-citation>
</ref>
<ref id="CIT0099">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Moresco</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Pietra</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Henin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Panzacchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Locatelli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bonaldi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Carpinelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gobbo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bellodi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Perani</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fazio</surname><given-names>F</given-names></name></person-group>(<year>2007</year>)<article-title>Fluvoxamine treatment and D<sup><sub>2</sub></sup> receptors: a pet study on OCD drug-naïve patients</article-title>. <source/>Neuropsychopharmacology<volume>32</volume>:<fpage>197</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">17019408</pub-id></mixed-citation>
</ref>
<ref id="CIT0100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Zickgraf</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Dingfelder</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Franklin</surname><given-names>ME</given-names></name></person-group>(<year>2013</year>)<article-title>Habit reversal training in trichotillomania: guide for the clinician</article-title>. <source/>Expert Rev Neurother<volume>13</volume>:<fpage>1069</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">23964997</pub-id></mixed-citation>
</ref>
<ref id="CIT0101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mowla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boostani</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dastgheib</surname><given-names>SA</given-names></name></person-group>(<year>2016</year>)<article-title>Duloxetine augmentation in resistant obsessive-compulsive disorder: a double-blind controlled clinical trial</article-title>. <source/>J Clin Psychopharmacol<volume>36</volume>:<fpage>720</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">27811556</pub-id></mixed-citation>
</ref>
<ref id="CIT0171">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mowla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Khajeian</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Sahraian</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chohedri</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Kashkoli</surname><given-names>F</given-names></name></person-group>(<year>2010</year>)<article-title>Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial</article-title>. <source/>CNS Spectr<volume>15</volume>:<fpage>613</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">24726048</pub-id></mixed-citation>
</ref>
<ref id="CIT0102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Monzani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rijsdijk</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Anson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lervolino</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Cherkas</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spector</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name></person-group>(<year>2012</year>)<article-title>A twin study of body dysmorphic concerns</article-title>. <source/>Psychol Med<volume>42</volume>:<fpage>1949</fpage>–<lpage>1955</lpage>.<pub-id pub-id-type="pmid">22126745</pub-id></mixed-citation>
</ref>
<ref id="CIT0103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nestadt</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Grados</surname><given-names>M</given-names></name>, and <name name-style="western"><surname>Samuels</surname><given-names>JF</given-names></name></person-group>(<year>2010</year>)<article-title>Genetics of OCD</article-title>. <source/>Psychiatr Clin North Am<volume>33</volume>:<fpage>141</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">20159344</pub-id></mixed-citation>
</ref>
<ref id="CIT0104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Odlaug</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name></person-group>(<year>2011</year>)<article-title>A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity</article-title>. <source/>Psychol Med<volume>41</volume>:<fpage>2111</fpage>–<lpage>2119</lpage>.<pub-id pub-id-type="pmid">21426627</pub-id></mixed-citation>
</ref>
<ref id="CIT0105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Palminteri</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Clair</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Mallet</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pessiglione</surname><given-names>M</given-names></name></person-group>(<year>2012</year>)<article-title>Similar improvement of reward and punishment learning by serotonin reuptake inhibitors in obsessive–compulsive disorder</article-title>. <source/>Biol Psychiatry<volume>72</volume>:<fpage>244</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">22325972</pub-id></mixed-citation>
</ref>
<ref id="CIT0106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JM</given-names></name><etal></etal></person-group> (<year>2016</year>)<article-title>ADHD and executive functioning deficits in OCD youths who hoard</article-title>. <source/>Psychiatr Res<volume>82</volume>:<fpage>141</fpage>–<lpage>148</lpage>.</mixed-citation>
</ref>
<ref id="CIT0108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Padhi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Farrow</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Mukhopadhaya</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Krishnaiah</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name></person-group> (<year>2010</year>) <article-title>The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis</article-title>. <source/>Psychol Med<volume>40</volume>:<fpage>921</fpage>–<lpage>933</lpage>.<pub-id pub-id-type="pmid">19818202</pub-id></mixed-citation>
</ref>
<ref id="CIT0172">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Paydary</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akamaloo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ahmadipour</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pishgar</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Emamzadehfard</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Akhondzadeh</surname><given-names>S</given-names></name></person-group>(<year>2016</year>)<article-title>N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial</article-title>. <source/>J Clin Pharm Ther<volume>41</volume>:<fpage>214</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">26931055</pub-id></mixed-citation>
</ref>
<ref id="CIT0109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perani</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garibotto</surname><given-names>V</given-names></name>,<name name-style="western"><surname>Gorini</surname><given-names>A</given-names></name></person-group>(<year>2008</year>)<article-title>In vivo PET study of 5HT<sub>2A</sub> serotonin and D<sub>2</sub> dopamine dysfunction in drug-naive obsessive-compulsive disorder</article-title>. <source/>Neuroimage<volume>42</volume>:<fpage>306</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">18511303</pub-id></mixed-citation>
</ref>
<ref id="CIT0110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Rauch</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fallon</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Barsky</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mataix-Cols</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ferrao</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wilhelm</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bienvenu</surname><given-names>OJ</given-names></name>, <name name-style="western"><surname>Farrow</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Beckman</surname><given-names>J</given-names></name></person-group>(<year>2010</year>)<article-title>Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V</article-title>?<source/>Depr Anxiety<volume>27</volume>:<fpage>528</fpage>–<lpage>555</lpage>.</mixed-citation>
</ref>
<ref id="CIT0111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Keshaviah</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dougherty</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Stout</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Menard</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wilhelm</surname><given-names>S</given-names></name></person-group>(<year>2016</year>)<article-title>Pharmacotherapy relapse prevention in body dysmorphic disorder: a double-blind, placebo-controlled trial</article-title>. <source/>Am J Psychiatry<volume>173</volume>:<fpage>887</fpage>–<lpage>895</lpage>.<pub-id pub-id-type="pmid">27056606</pub-id></mixed-citation>
</ref>
<ref id="CIT0112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pitman</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Jenike</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mesulam</surname><given-names>MM</given-names></name></person-group>(<year>1987</year>)<article-title>Clinical comparison of Tourette’s disorder ad obsessive compulsive disorder</article-title>. <source/>Am J Psychiatry<volume>144</volume>:<fpage>1166</fpage>–<lpage>1171</lpage>.<pub-id pub-id-type="pmid">3477103</pub-id></mixed-citation>
</ref>
<ref id="CIT0113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Prado</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Rosario</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hounie</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name></person-group>(<year>2008</year>)<article-title>Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature</article-title>. <source/>CNS Spectr<volume>13</volume>:<fpage>425</fpage>–<lpage>432</lpage>.<pub-id pub-id-type="pmid">18496480</pub-id></mixed-citation>
</ref>
<ref id="CIT0114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Purcell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Maruff</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kyrios</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pantelis</surname><given-names>C</given-names></name></person-group> (<year>1998a</year>) <article-title>Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function</article-title>. <source/>Biol Psychiat<volume>43</volume>:<fpage>348</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">9513750</pub-id></mixed-citation>
</ref>
<ref id="CIT0115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Purcell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Maruff</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kyrios</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pantelis</surname><given-names>C</given-names></name></person-group> (<year>1998b</year>) <article-title>Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls</article-title>. <source/>Archs Gen Psychiat<volume>55</volume>:<fpage>415</fpage>–<lpage>423</lpage>.</mixed-citation>
</ref>
<ref id="CIT0116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rapoport</surname><given-names>JL</given-names></name></person-group>(<year>1989</year>)<article-title>The biology of obsessions and compulsions</article-title>. <source/>Sci Am<volume>260</volume>:<fpage>82</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">2648564</pub-id></mixed-citation>
</ref>
<ref id="CIT0117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name></person-group>(<year>2015</year>)<article-title>Adjunctive antipsychotic in the treatment of body dysmorphic disorder - a retrospective naturalistic case note study</article-title>. <source/>Int J Psychiatry Clin Pract<volume>19</volume>:<fpage>84</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">25363200</pub-id></mixed-citation>
</ref>
<ref id="CIT0118">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>LR</given-names></name></person-group>(<year>1998</year>)<article-title>Neuroimaging in obsessive-compulsive disorder and related disorder</article-title>. In: <source/>Obsessive-compulsive disorder: practical management (<person-group person-group-type="editor"><name name-style="western"><surname>Jenicke</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Baer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Minichiello</surname><given-names>WE</given-names></name></person-group>, eds), <edition>3rd ed</edition>
<publisher-loc>St Louis</publisher-loc>: <publisher-name>Mosby</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Makris</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cosgrove</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Cassem</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Savage</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Nierenberg</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Shera</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Baer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Buchbinder</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Caviness</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Jenike</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>DN</given-names></name></person-group>(<year>2000</year>)<article-title>Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study</article-title>. <source/>J Neurosurg<fpage>1019</fpage>–<lpage>1025</lpage>.<pub-id pub-id-type="pmid">11117844</pub-id></mixed-citation>
</ref>
<ref id="CIT0120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rauch</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Whalen</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Curran</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Coffey</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Savage</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Mclnerney</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Baer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jenike</surname><given-names>MA</given-names></name></person-group>(<year>2001</year>)<article-title>Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods</article-title>. <source/>Adv Neurol<volume>85</volume>:<fpage>207</fpage>–<lpage>224</lpage>.<pub-id pub-id-type="pmid">11530429</pub-id></mixed-citation>
</ref>
<ref id="CIT0176">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group> (<year>2015a</year>) <source/>Pathogenesis. In: Obsessive-compulsive and related disorders (<person-group person-group-type="editor"><name name-style="western"><surname>Stein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name></person-group>, eds), <edition>2nd</edition> ed, p<fpage>13</fpage>–<lpage>35</lpage>. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford Psychiatry Library Series</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0121">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group>(<year>2015b</year>)<article-title>Psychotherapy, an integrated approach</article-title>. In: <source/>Obsessive-compulsive and related disorders (<person-group person-group-type="editor"><name name-style="western"><surname>Stein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name></person-group>, eds), <edition>2nd ed</edition>, p<fpage>62</fpage>
<publisher-loc>New York</publisher-loc>: <publisher-name>Oxford Psychiatry Library Series</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0177">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Reghunandanan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group> (<year>2015c</year>) <source/>Pharmacotherapy and somatic treatments. In: Obsessive-compulsive and related disorders (<person-group person-group-type="editor"><name name-style="western"><surname>Stein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name></person-group>, eds), <edition>2nd</edition> ed, p<fpage>37</fpage>–<lpage>59</lpage>. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford Psychiatry Library Series</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reimold</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Smolka</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Batra</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Knobel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Solbach</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mundt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Smoltczyk</surname><given-names>HU</given-names></name>, <name name-style="western"><surname>Goldman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Reischl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Machulla</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Bares</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heinz</surname><given-names>A</given-names></name></person-group>(<year>2007</year>)<article-title>Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity – a [<sup>11</sup>C] DASB PET study</article-title>. <source/>J Neural Transm (Vienna)<volume>114</volume>:<fpage>1603</fpage>–<lpage>1609</lpage>.<pub-id pub-id-type="pmid">17713719</pub-id></mixed-citation>
</ref>
<ref id="CIT0123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Remijnse</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nielen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Balkom</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cath</surname><given-names>D</given-names></name>, <name name-style="western"><surname>van Open</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Uylings</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>D</given-names></name></person-group>(<year>2006</year>)<article-title>Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder</article-title>. <source/>Arch Gen Psychiatry<volume>63</volume>:<fpage>1225</fpage>–<lpage>1236</lpage>.<pub-id pub-id-type="pmid">17088503</pub-id></mixed-citation>
</ref>
<ref id="CIT0124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ersche</surname><given-names>KD</given-names></name></person-group>(<year>2012</year>)<article-title>Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry</article-title>. <source/>Trends Cogn Sci<volume>16</volume>:<fpage>81</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">22155014</pub-id></mixed-citation>
</ref>
<ref id="CIT0173">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>CI</given-names></name>, <name name-style="western"><surname>Kegeles</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Levinson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Marcus</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Vermes</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Flood</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>HB</given-names></name></person-group>(<year>2013</year>)<article-title>Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept</article-title>. <source/>Neuropsychopharmacology<volume>38</volume>: <fpage>2475</fpage>–<lpage>2483</lpage>.<pub-id pub-id-type="pmid">23783065</pub-id></mixed-citation>
</ref>
<ref id="CIT0125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Grasby</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2000</year>)<article-title>Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans</article-title>. <source/>J Cogn Neurosci<volume>12</volume>:<fpage>142</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">10769312</pub-id></mixed-citation>
</ref>
<ref id="CIT0126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Keshavan</surname><given-names>MS</given-names></name></person-group>(<year>1998</year>)<article-title>Toward a neurodevelopmental model of obsessive-compulsive disorder</article-title>. <source/>Biol Psychiatry<volume>43</volume>:<fpage>623</fpage>–<lpage>640</lpage>.<pub-id pub-id-type="pmid">9582996</pub-id></mixed-citation>
</ref>
<ref id="CIT0127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>MacMaster</surname><given-names>FP</given-names></name>, <name name-style="western"><surname>Keshavan</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>GJ</given-names></name></person-group>(<year>2000</year>)<article-title>Decrease in caudate glutamate concentration in pediatric obsessive-compulsive disorder patients taking paroxetine</article-title>. <source/>J Am Acad Child Adolesc Psychiatry<volume>39</volume>:<fpage>1096</fpage>–<lpage>1103</lpage>.<pub-id pub-id-type="pmid">10986805</pub-id></mixed-citation>
</ref>
<ref id="CIT0128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>MacMillan</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>GJ</given-names></name></person-group>(<year>2001</year>). <article-title>Brain anatomy and chemistry may predict treatment response in pediatric obsessive-compulsive disorder</article-title>. <source/>Int J Neuropsychopharmacol<volume>4</volume>:<fpage>179</fpage>–<lpage>190</lpage>.<pub-id pub-id-type="pmid">11466168</pub-id></mixed-citation>
</ref>
<ref id="CIT0129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rothbart</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Amos</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Siegfried</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ipser</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group>(<year>2013</year>)<article-title>Pharmacotherapy for trichotillomania</article-title>. <source/>Cochrane Database Syst Rev<volume>11</volume>:<fpage>CD007662</fpage>.</mixed-citation>
</ref>
<ref id="CIT0130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rubia</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Brammer</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>E</given-names></name></person-group>(<year>2003</year>)<article-title>Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection</article-title>. <source/>Neuroimage<volume>20</volume>:<fpage>351</fpage>–<lpage>358</lpage>.<pub-id pub-id-type="pmid">14527595</pub-id></mixed-citation>
</ref>
<ref id="CIT0174">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Sachdev</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Ruparelia</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Mpavenda</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cinosi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name></person-group>(<year>2017</year>)<source/>Pharmacological Treatments for Obsessive Compulsive and Related Disorders - A Trans-Diagnostic Perspective. In: A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena (<person-group person-group-type="editor"><name name-style="western"><surname>Fontanelle</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yucel</surname><given-names>M</given-names></name></person-group>, eds), Chapter 17. <publisher-name>Cambridge University Press</publisher-name>. In press, Oct 2017.</mixed-citation>
</ref>
<ref id="CIT0175">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sarris</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Camfield</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Dean</surname><given-names>OM</given-names></name>, <name name-style="western"><surname>Dowling</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Menon</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Berk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Blair-West</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>CH</given-names></name></person-group>(<year>2015</year>)<article-title>N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study</article-title>. <source/>CNS Drugs<volume>29</volume>:<fpage>801</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="pmid">26374743</pub-id></mixed-citation>
</ref>
<ref id="CIT0131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brody</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Maidment</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Zohrabi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>LR</given-names></name></person-group>(<year>2004</year>)<article-title>Cerebral glucose metabolism in obsessive-compulsive hoarding</article-title>. <source/>Am J Psychiat<volume>161</volume>:<fpage>1038</fpage>–<lpage>1048</lpage>.<pub-id pub-id-type="pmid">15169692</pub-id></mixed-citation>
</ref>
<ref id="CIT0132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sumner</surname><given-names>J</given-names></name></person-group>(<year>2014</year>)<article-title>Venflaxine extended release treatment of hoarding disorder</article-title>. <source/>Int Clin Psychopharmacol<volume>29</volume>:<fpage>266</fpage>–<lpage>273</lpage>.<pub-id pub-id-type="pmid">24722633</pub-id></mixed-citation>
</ref>
<ref id="CIT0133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schiller</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Niv</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>LeDoux</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Phelps</surname><given-names>EA</given-names></name></person-group>(<year>2008</year>)<article-title>From fear to safety and back: reversal of fear in the human brain</article-title>. <source/>J Neurosci<volume>28</volume>:<fpage>11517</fpage>–<lpage>11525</lpage>.<pub-id pub-id-type="pmid">18987188</pub-id></mixed-citation>
</ref>
<ref id="CIT0134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schwabe</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>OT</given-names></name></person-group>(<year>2009</year>)<article-title>Stress prompts habit behavior in humans</article-title>. <source/>J Neurosci<volume>29</volume>:<fpage>7191</fpage>–<lpage>7198</lpage>.<pub-id pub-id-type="pmid">19494141</pub-id></mixed-citation>
</ref>
<ref id="CIT0135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Senço</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>D’Urso</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Parra</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Bikson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shavitt</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Hoexter</surname><given-names>MQ</given-names></name>, <name name-style="western"><surname>Miguel</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Brunoni</surname><given-names>AR</given-names></name></person-group>(<year>2015</year>)<article-title>Transcranial direct current stimulation in obsessive-compulsive disorder: emerging clinical evidence and considerations for optimal montage of electrodes</article-title>. <source/>Expert Rev Med Devices<volume>12</volume>:<fpage>381</fpage>–<lpage>391</lpage>.<pub-id pub-id-type="pmid">25982412</pub-id></mixed-citation>
</ref>
<ref id="CIT0136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Skapinakis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Hollingworth</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bryden</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Salkovskis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Welton</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kessler</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Churchill</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>G</given-names></name></person-group>(<year>2016</year>)<article-title>Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis</article-title>. <source/>Lancet Psychiatry<volume>3</volume>:<fpage>730</fpage>–<lpage>739</lpage>.<pub-id pub-id-type="pmid">27318812</pub-id></mixed-citation>
</ref>
<ref id="CIT0137">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>L</given-names></name></person-group>(<year>1994</year>)<article-title>Neuropsychiatry of obsessive-compulsive disorder</article-title>. In: <source/>Current insights in obsessive-compulsive disorder (<person-group person-group-type="editor"><name name-style="western"><surname>Hollander</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zohar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marazziti</surname><given-names>D</given-names></name>, and <name name-style="western"><surname>Olivier</surname><given-names>B</given-names></name></person-group> eds). <publisher-loc>Chichester</publisher-loc>: <publisher-name>Wiley</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0138">
<mixed-citation publication-type="book">
<person-group person-group-type="editor"><name name-style="western"><surname>Steketee</surname><given-names>G</given-names></name></person-group>, ed (<year>2011</year>)<source/>The Oxford handbook of obsessive compulsive and spectrum disorders. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0139">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Szeszko</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Alvir</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bilder</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Lenz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ashtari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bogerts</surname><given-names>B</given-names></name></person-group>(<year>1999</year>)<article-title>Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder</article-title>. <source/>Archs Gen Psychiat<volume>56</volume>:<fpage>913</fpage>–<lpage>919</lpage>.</mixed-citation>
</ref>
<ref id="CIT0140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tricomi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Balleine</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>O’Doherty</surname><given-names>JP</given-names></name></person-group>(<year>2009</year>)<article-title>A specific role for posterior dorsolateral striatum in human habit learning</article-title>. <source/>Eur J Neurosci<volume>29</volume>:<fpage>2225</fpage>–<lpage>2232</lpage>.<pub-id pub-id-type="pmid">19490086</pub-id></mixed-citation>
</ref>
<ref id="CIT0141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Uhm</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Tsoh</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Mackin</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Gause</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Franklin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eckfield</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vigil</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bain</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vega</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Delucchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>CA</given-names></name></person-group>(<year>2016</year>)<article-title>Comparison of a peer facilitated support group to cognitive behavior therapy: study protocol for a randomised controlled trial for hoarding disorder</article-title>. <source/>Contemp Clin Trials<volume>50</volume>:<fpage>98</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">27444427</pub-id></mixed-citation>
</ref>
<ref id="CIT0142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vaghi</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Vértes</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Kitzbichler</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Apergis-Schoute</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>van der Flier</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sule</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zaman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kundu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2016</year>)<article-title>Specific frontostriatal circuits for impaired cognitive flexibility and goal-directed planning in obsessive-compulsive disorder: evidence from resting-state functional connectivity</article-title>. <source/>Biol Psychiatry<volume>81</volume>:<fpage>708</fpage>–<lpage>717</lpage>.<pub-id pub-id-type="pmid">27769568</pub-id></mixed-citation>
</ref>
<ref id="CIT0143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Ameringen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mancini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oakman</surname><given-names>J</given-names></name></person-group>(<year>2010</year>)<article-title>A randomised, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania</article-title>. <source/>J Clin Psychiatry<volume>71</volume>:<fpage>1336</fpage>–<lpage>1343</lpage>.<pub-id pub-id-type="pmid">20441724</pub-id></mixed-citation>
</ref>
<ref id="CIT0144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>van den Heuvel</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>van der Werf</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Verhoef</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Wolters</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Groenewegen</surname><given-names>HJ</given-names></name></person-group>(<year>2010</year>)<article-title>Frontal-striatal abnormalities underlying behaviors in the compulsive-impulsive spectrum</article-title>. <source/>J Neurol Sci<volume>289</volume>:<fpage>55</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">19729172</pub-id></mixed-citation>
</ref>
<ref id="CIT0145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Veale</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Anson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Miles</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pieta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ellison</surname><given-names>N</given-names></name></person-group>(<year>2014</year>)<article-title>Efficacy of cognitive behavior therapy vs anxiety management for body dysmorphic disorder: a randomised controlled trial</article-title>. <source/>Psychother Psychosom<volume>83</volume>:<fpage>341</fpage>–<lpage>353</lpage>.<pub-id pub-id-type="pmid">25323062</pub-id></mixed-citation>
</ref>
<ref id="CIT0146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Derbyshire</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rück</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Irvine</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Worbe</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Enander</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Gillan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sahakian</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Daw</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Dayan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Bullmore</surname><given-names>ET</given-names></name></person-group> (<year>2015a</year>) <article-title>Disorders of compulsivity: a common bias towards learning habits</article-title>. <source/>Mol Psychiatry<volume>20</volume>:<fpage>345</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">24840709</pub-id></mixed-citation>
</ref>
<ref id="CIT0147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Voon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Baek</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Enander</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Worbe</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rück</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Daw</surname><given-names>N</given-names></name></person-group> (<year>2015b</year>) <article-title>Motivation and value influences in the relative balance of goal-directed and habitual behaviors in obsessive-compulsive disorder</article-title>. <source/>Transl Psychiatry<volume>5</volume>:<fpage>e670</fpage>.<pub-id pub-id-type="pmid">26529423</pub-id></mixed-citation>
</ref>
<ref id="CIT0148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Whiteside</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Port</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Abramowitz</surname><given-names>JS</given-names></name></person-group>(<year>2004</year>)<article-title>A meta-analysis of functional neuroimaging in obsessive-compulsive disorder</article-title>. <source/>Psychiatry Res<volume>132</volume>:<fpage>69</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">15546704</pub-id></mixed-citation>
</ref>
<ref id="CIT0149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Whiteside</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Abramowitz</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Port</surname><given-names>JD</given-names></name></person-group>(<year>2012</year>)<article-title>Decreased caudate N-acetyl-l-aspartic acid in pediatric obsessive-compulsive disorder and the effects of behavior therapy</article-title>. <source/>Psychiatry Res<volume>202</volume>:<fpage>53</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">22704757</pub-id></mixed-citation>
</ref>
<ref id="CIT0150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wikramanayake</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mandy</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shahper</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kaur</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kolli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Osman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jefferies-Sewell</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fineberg</surname><given-names>N</given-names></name></person-group>(<year>2017</year>)<article-title>Autism spectrum disorder in adult outpatients with obsessive compulsive disorder in the UK</article-title>. <source/>Int J Psychiatry Clin Pract Aug<volume>11</volume>:<fpage>1</fpage>–<lpage>9</lpage>. doi: <comment>org/10.1080/13651501.2017.1354029</comment>.</mixed-citation>
</ref>
<ref id="CIT0151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Worbe</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Savulich</surname><given-names>G</given-names></name>, <name name-style="western"><surname>deWit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fernandez-Egea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name></person-group>(<year>2015</year>)<article-title>Tryptophan depletion promotes habitual over goal-directed control of appetitive responding in humans</article-title>. <source/>Int J Neuropsychopharmacol doi: <comment>10.1093/ijnp/pyv013</comment>.</mixed-citation>
</ref>
<ref id="CIT0152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Worbe</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Palminteri</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Savulich</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Daw</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Fernandez-Egea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Voon</surname><given-names>V</given-names></name></person-group>(<year>2016</year>)<article-title>Valence-dependent influence of serotonin depletion on model-based choice strategy</article-title>. <source/>Mol Psychiatry<volume>21</volume>:<fpage>624</fpage>–<lpage>629</lpage>.<pub-id pub-id-type="pmid">25869808</pub-id></mixed-citation>
</ref>
<ref id="CIT0153">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>World Health Organisation</collab></person-group>(<year>1992</year>)<source/>ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organisation</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT2325">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>World Health Organisation</collab></person-group>(<year>2010</year>)<source/>International statistical classification of diseases and related health problems. 10th rev. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO Press</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0154">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yucel</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fornito</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Wellard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pujol</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Philips</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kyrios</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Velakoulis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pantelis</surname><given-names>C</given-names></name></person-group>(<year>2007</year>)<article-title>Functional and biochemical alternations of the medial frontal cortex in obsessive-compulsive disorder</article-title>. <source/>Arch Gen Psychiatry<volume>64</volume>:<fpage>946</fpage>–<lpage>955</lpage>.<pub-id pub-id-type="pmid">17679639</pub-id></mixed-citation>
</ref>
<ref id="CIT0155">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zungu-Dirwayi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hugo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>van Heerden</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>DJ</given-names></name></person-group>(<year>1999</year>)<article-title>Are musical obsessions a temporal lobe phenomenon</article-title>?<source/>J Neuropsychiat Clin Neurosci<volume>11</volume>:<fpage>398</fpage>–<lpage>400</lpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>